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1. Abstract  
Backround: Meat and animal products are one of the most favourite foods in the 
western world. There are some high protein (HP) studies that show a positive effect 
on on sarcopenia, glucose homeostasis, bone health, weight management and 
satiety. But there are only a few studies that characterise the physiological effects of 
a HP diet. Further there is no study done yet that investigate the impact of a HP diet 
on certain proteomes.  
Objective: In this study the impact of an HP diet on platelet proteome was explored, 
whereas the platelets were used as a model for muscle cells since they have several 
similarities like the contractile protein system. Further there are several studies 
concerning changed protein diet and the homocysteine pathway. However, their 
results are very contradictorily. In this study we want to adduce the final evidence 
about the correlation of homocysteine, folate and vitamin B12 and a HP diet.  
Methods: In this randomised intervention study 23 young men took part. In the one 
week run in period all individuals consumed a normal protein (NP) diet (1.5 g 
protein/kg body weight). In the intervention period they were separated into two 
groups: a HP group (3.0 g protein/kg body weight) and a NP group. In both diets the 
protein derived from an animal source. Intervention time lasted for 3 weeks. Blood 
was taken and cognitive tests were performed at the beginning and at the end of the 
intervention time. Platelets were isolated and analysed with 2 D DIGE analysis.  
Results: The protein that showed the strongest effect with HP diet in platelets was 
Monoamine oxidase B (Mao-B) wich is a dopamine degrading enzyme. It was 
significantly decreased with HP diet. Vitamin B12 concentration was significantly 
increased with HP diet in plasma and correlated inversely with the Mao-B 
concentration in platelets. Further the improvement of a reaction time test correlated 
with the decrease of Mao-B in plateles.  
Discussion: The inverse correlation between vitamin B12 and Mao-B could indicate 
that vitamin B12 is directly regulating Mao-B expression. Further the improved 
reaction time indicates enhanced cognitive functions when consuming an animal HP 
diet. These improved cognitive functions could be explained with the correlation of 
the reaction time test, Mao-B and components of the methylation cycle like vitamin 
B12. 
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2. Zusammenfassung 
Hintergrund: Fleisch und tierische Produkte sind eines der beliebtesten 
Nahrungsmittel in der westlichen Welt. Es gibt einige Studien über erhöhten Protein 
Konsum die einen positiven Effekt in Bezug auf Sarkopenie, Glukose Homeostase, 
Knochengesundheit, Gewichtsmanagement und Sättigungsgefühl zeigen. Es gibt 
jedoch nur wenige Studien, die die physiologischen Effekte einer Ernährung mit 
erhöhtem Proteinanteil zeigen. Weiters wurde bis jetzt noch keine Studie 
durchgeführt, die sich auf den Einfluss einer Diät mit erhöhtem Proteinanteil auf 
Proteome konzentriert. 
Zielsetzung: In dieser Studie wurde der Einfluss einer Diät mit erhöhtem 
Proteinanteil auf das Thrombozytenproteoem untersucht, wobei Thrombozyten als 
Modell für Muskelzellen verwendet wurden, da diese verschiedene Ähnlichkeiten 
besitzen, wie zum Beispiel das kontraktile System. Weiters gibt es einige Studien die 
den Zusammenhang von Diäten mit verschiedenen Proteinmengen mit dem 
Homocysteinzyklus beschreiben. Diese sind jedoch sehr widersprüchlich. In dieser 
Studie wollen wir den eindeutigen Beweis für einen Zusammenhang von 
Homozystein, Folat und Vitamin B12 mit einer Diät mit erhöhtem Proteinanteil 
beweisen. 
Methoden: An dieser randomisierten Studie nahmen 23 junge Männer teil. In einer 
einwöchigen Einlaufphase konsumierten alle Teilnehmer eine Diät mit einer normalen 
Menge an Protein (1,5 g Protein/kg Körpergewicht). In der Interventionszeit wurden 
sie in zwei Gruppen aufgeteilt: eine Gruppe mit erhöhtem Proteinkonsum (3,0 g 
Protein/kg Körpergewicht) und eine Gruppe mit normalem Proteinkonsum. Bei beiden 
Diäten war die Proteinquelle eine tierische. Die Interventionszeit dauerte 3 Wochen. 
Zu Beginn und am Ende der Interventionszeit wurde den Probanden Blut 
abgenommen und kognitive Tests wurden durchgeführt. Die Thrombozyten wurden 
isoliert und mittels 2 D DIGE Analyse analysiert.  
Ergebnisse: Das Protein das den stärkesten Effekt nach einer Diät mit erhöhtem 
Proteinanteil zeigte ist Monoaminoxidase B (Mao-B), welches ein Dopamin 
abbauendes Enzym ist. Es war signifikant vermindert nach einer erhöhten Protein 
Diät. Die Vitamin B12 Konzentration im Plasma war signifikant erhöht nach einer 
erhöhten Proteindiät und korrelierte invers mit der Mao-B Konzentration in den 
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Thrombozyten. Weiters korrelierten die Ergebnisse des Reaktionstests mit dem 
Abfall von Mao-B in Thrombozyten.  
Diskussion: Die inverse Korrelation von Vitamin B12 mit Mao-B könnte daruf 
hindeuten, dass Vitamin B12 Mao-B direkt reguliert. Weiters zeigt die verbesserte 
Reaktionszeit verbesserte kognitive Funktionen bei einer erhöhten Protein Diät auf 
tierischer Basis. Diese verbesserten kognitiven Funktionen könnten durch die 
Korrelationen von Reaktionstest, Mao-B und den Komponenten des 
Methylierungszyklus, wie z.B.: Vitamin B12, erklärt werden. 
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3. Introduction 
Meat intake is an important contributor to dietary protein and therefore has a potential 
impact on a range of nutritional and health outcomes. In western countries meat is an 
important part of the daily menu. Especially in Austria meat is one of the most 
favourite foods. (Grüner Bericht 2004) 
Nitrogen balance studies have led to the calculation of the RDA (recommended 
dietary allowance) for protein for young healthy adults.(Campbell 2002; Castaneda 
1995) However, only a few studies have addressed the question about the 
biochemical consequences of changed protein amount intake in humans. Also most 
of the studies that were done concern low protein intake. Castenada et al. showed for 
example that a low protein diet in elderly women (0.45 g protein / kg / day compared 
to 0.92 g protein / kg / day) leads to a significant loss of muscle function, immune 
response and lean tissue mass, though they all had a neutral nitrogen balance, after 
a 9 weeks study period. (Castaneda 1995) 
There are some high protein (HP) studies showing a positive effect on sarcopenia, 
glucose homeostasis, bone health, weight management and satiety (Rodriguez 
2008) but only a few studies that address the physiological effects. Mikkelsen et al. 
showed for example that a HP diet increases the 24 h energy expenditure with 3% 
compared to a low protein diet. Further they showed that animal protein induced 2 % 
higher increase in 24 h energy expenditure than vegetable protein did. (Mikkelsen 
2000) 
Although an increased meat diet is frowned upon, relatively little evidence has been 
gathered regarding the effect of protein on the development of chronic diseases. 
While there was initial suspicion that HP diets increased the risk for renal failure, 
studies have shown that kidney problems occur only in people with pre-existing 
kidney disease. It has also been shown that there is no correlation between HP, 
animal HP diet and gout. Gout is the most common form of inflammatory arthritis. 
(Choi 2004) It is arising by the release of monosodium urate cristals into synovial 
spaces, causing an inflammatory response and thereby the recurrent attact of acute 
arthritis. (Williams 2008) Since uric acid is the end product of the purine metabolism, 
and purine derives mainly from diet, gout is significanty influenced by nutrition. Purine 
rich foods and beverages are meat (especially offal) beer and some vegetables like 
spinach, peas, beans, mushrooms and asparagus. Low purine foods are for examle 
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dairy products or fruits. (Fam 2002) Choi et al. showed a coherence between 
increased meat consumption and gout, but as said before there was no coherence 
found regarding to an animal HP diet, since this includes dairy product which 
decrease the risk. (Choi 2004)  
In recent years, health concerns have been raised about the consumption of meat 
increasing the risk of cancer. Taylor et al. found a correlation between meat 
consumption and the risk for breast cancer in pre- and postmenopausal women. 
(Taylor 2007) Another study showed that increased red and processed meat 
consumption can increas the risk for pancreatic cancer. (Nothlings 2005) 
Only a few studies have concentrated on the physiological effects of a HP diet that 
derives from animal source. In order to understand the possible effect of animal HP 
intake on physiological functions, it is necessary to know the underlying cause of 
change in the cell (Proteomics), and the relation between these changes and 
biochemical regulators of the processes.  
In this study probable changes in plasma proteome, plasma amino acids and in 
platelets proteome were examined. Platelets were used as a peripheral model for 
muscle cells. 
 
3.1. Digestion and absorption of proteins and amino acids – protein 
and amino acid metabolism 
In order to follow the effects of a HP diet in blood it is essential to track all pathways 
and start thereby in the mechanisms of digestion and absorption of alimentary 
proteins and amino acids.  
After food intake the gastric acid starts to cleave proteins partially and hydrolyses 
them partially to peptides. Additionally, the gastric acid catalyses the formation of 
pepsin from pepsinogen. Pepsin can cleave all proteins (except keratin and myosin) 
to polypeptides. Supplementary trypsin and chymotrypsin, derived from pancreatic 
juice, hydrolyse proteins to polypeptides in the small intestine.  
In the small intestine there are several ezymes – like enterokinase, elastase, 
dipeptidase, aminopeptidase or prolidase – that cleave polypeptides and peptones to 
dipeptides and amino acids.  
Amino acids are absorbed rapidly out of the gut lumen, whereas small peptides are 
hydrolyzed to amino acids when entering the mucosa cells. Only free amino acids 
can make their way to the liver. There are several transport mechanisms that vary in 
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specificity and velocity but all of them need a free amino group in α-position of the 
amino acid.  
Vegetable protein is harder to absorb for the human body than animal protein 
because of the cell wall. 90 % of alimentary protein is absorbed and processed by the 
body. 
After the transport to the liver, the free amino acids get processed. Liver and kidneys 
are the most important organs for amino acid metabolism. One part of the amino 
acids is catabolised in different procedures to store the carbon scaffold as glycogen 
or fat. The amino group is used for the urea cycle. Some of the degradation products 
are intermediates of the citric acid cycle. Another part of the amino acids is used for 
the formation of tissue proteins. Most of the amino acids used for this purpose are 
amino acids from catabolised tissue proteins that were transported back to liver or 
kidney for recycling. The third main application for free amino acids is the formation 
of nitrogen containing products like purine bases, creatine or adrenalin. Additionally 
the non-essential amino acids are required for the transformation into essential amino 
acids.  
Alimentary proteins are important for several reasons: synthesis of body mass 
(especially in children and pregnant women), novel synthesis of proteins that were 
catabolised in metabolism, they can act as enzymes, hormones, transporters, plasma 
proteins for maintenance of osmotic proportion, antibodies and clotting factors, 
contractile proteins in muscle tissue and as an important part of cells and tissues. 
(Elmadfa 1998) 
 
3.2. Amino acids 
Since dietry protein gets catabolized into amino acids during digestion, an analysis of 
the plasma amino acids in an HP study is very important. It has been shown in rat 
skeletal muscle that the amino acid concentration plays a crucial role in translational 
regulation. With amino acid supplementation the protein synthesis rate could be 
increased twofold. (Vary 1999) Further it was shown that both intravenous (Volpi 
1998) and oral amino acid supplementation increased skeletal muscle protein 
synthesis in elderly. (Paddon-Jones 2004) 
Amino acids can be separated into proteinogenic amino acids and nonproteinogenic 
amino acids. The function of proteinogenic amino acids is to be building block of 
proteins and the one of nonproteinogenic amino acids is to attend metabolism.  
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Amino acids are chiral (except Glycin). There are 20 proteinogenic amino acids, 
which are all L-α-amino acids.  
More than 100 nonproteinogenic amino acids are known so far. Nearly all of them are 
derivatives of proteinogenic amino acids. They function as intermediates of 
proteinogen amino acids in metabolism, precursors of low-molecular compounds and 
they are important in biosynthesis of urea. (Löffler 2002a) 
Amino acids can be devided into essential, semi-essential and non-essential. 
Essential amino acids are amino acids that are necessary but cannot be synthesized 
by the human body. They have to be supplied through food. There are eight amino 
acids that are essential for humans: isoleucine, leucine, lysine, methionine, 
phenylalanine, threonine, tryptophan and valine.  
Semi-essential amino acids can be synthesized by the body but in case of injury or 
during growth they have to be conducted with food. Tyrosine and cysteine are semi-
essential amino acids.  
Non-essential amino acids can be synthesized from carbon compounds and 
ammonia by the human body. They don’t have to be delivered to the body by food 
necessarily. Non-essential amino acids are: apartate, asparagine, glutamate, 
glutamine, glycine, alanine, serine, proline and arginine. (Löffler 2002b) 
 
3.3. Muscle cells 
As described above an amino acid supplementation can increase skeletal muscle 
protein synthesis in elderly and thereby could decrease the risk of sarcopenia. 
(Paddon-Jones 2004; Volpi 1998) Sarcopenia is the degenerative loss of skeletal 
muscle mass and strength and is strongly associated with aging. One of the main 
mechanisms contributing to sarcopenia is the declining muscle protein synthesis in 
ageing. (Short 2004) So with a HP diet there may also be an effect on the skeletal 
muscle protein synthesis.  
 
3.3.1. Skeletal muscle cells - Physiology 
Muscle cell is an umbrella term for several kinds of cell types which all have a 
contractile system involving actin and myosin. In mammals four main classes of 
muscle cells are present: skeletal muscle, heart (cardiac) muscle, smooth muscle 
cells and myoepithelial cells. (Alberts 2002b) 
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Skeletal muscles account for 40 % of the body weight and are responsible for almost 
all intended movements. Skeletal muscle cells, also called muscle fibres, consist of 
syncytia i.e. multinucleated cells. In adult persons muscle cells can have a diameter 
around 15-200 µm and a length up to 15 cm. Muscle fibres are condensed to a 
muscle bundle which are condensed to the muscle itself. The cytoplasm membrane 
contains a collagen layer which ends in sinew at the end of the muscle. In the 
cytoplasm the sarcomeres - contractile units that consist of actin and myosin – form 
the myofibril. Further the sarkoplasmatic reticulum, several nuclei and a large number 
of mitochondria are located in the cytoplasm. (Speckmann 2008)  
 
3.3.2. Skeletal muscle cells - Contraction 
Myofibrils, that are nearly as long as the muscle fibre itself, consist of many 
contractile subunits called sarcomeres. They down date its striated appearance and 
consist of overlapping thick and thin filaments. The thin filaments consist of actin and 
are fixed at the Z disc with the plus end at the end of each sarcomere. The thick 
filaments consist of bipolar myosin II structures. Several accessory proteins are 
responsible for the uniformity in filament organisation, like the already mentioned Z-
disc which consists of CapZ and α-actin, nebulin or Titin which functions a “feather” 
against overexpansion of the muscle (see figure 1).  
 
 
 
Figure 1: Filament organisation of sceletal muscle cells. Actin thin filaments are attached to 
the Z disk. Nebulin is attached at the thin filaments and the Z disk. Titin connects the myosin 
thick filament with the Z disk. Mayosin thick filament is attchaed to the actin thin filament. 
(Lodish 2000) 
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At the start of contraction the myosin head is attached to the actin filament. One 
molecule of ATP binds which implicates a slight conformation change in the inner of 
the protein which results in a movement for 5nm which leads to a reduction of affinity 
to the actin filament. ATP gets hydrolysed to ADP and Pi and affinity increases again. 
The myosin head can bind to the actin filament 5 nm farther. This mechanism - 
performed with a high number of motor domains of the myosin II filaments at the 
same time - enables the sarcomere to shorten for 10% in less than 1/50 second. For 
proper muscle contraction rapidly large amounts of ATP molecules are needed. 
(Alberts 2002a) 
Muscle contraction is induced by increased calcium concentration in the cytosol 
implied by an arriving action potential at the neuromuscular end-plate. When the 
action potential reaches the sarcolemma, calcium ions can invade the muscle fibres 
through voltage dependent calcium channels. The muscle fibres get activated and 
the muscle tenses. The calcium channels stay open as long as the action potential 
sustains. (Löffler 2002c) 
 
3.4. Blood platelets 
3.4.1. Blood platelets as a peripheral model for muscle cells 
Since muscle biopsies in many clinical study settings are too elaborate and costly 
and also not suitable for routine diagnostic we decided to study possible biochemical 
mechanisms of a HP diet on muscle cells, in blood platelets which are described to 
reflect several structural and biochemical features of muscle cells. 
Like muscle cells platelets have a predominantly aerobic glycolytic metabolism and 
considerable glycogen stores. Also the energy metabolism is analogical in both cell 
types. Blood platelets and muscle cells both perform glycolysis actively and for ATP 
generation they are using large amounts of glycogen. Platelets have to be able to 
deliver large amounts of energy very fast.This energy is needed for aggregation, 
granule release and clot retraction. (Gnatenko 2003; Karpatkin 1970)  
Like muscle cells, platelets are contractile and motile. Also in proteome composition 
they have several similarities. Both cell types retain large quantities of actin, myosin 
and regulatory proteins like gelsolin and actin-binding protein. Further the Ca2+-
transport system in platelets has several similarities to the one in muscle cells. The 
Ca2+ storage organelle in platelets is called dense tubular system and is analogous to 
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the sarcoplasmatic reticulum of muscle. Further the surface-connected canalicular 
system can be compared to the T-tubule system in muscle cells. (Fischer 1989) 
 
3.4.2. General abilities of platelets 
Blood platelets are the smallest cells that circulate in blood. They have a diameter of 
1 – 4 µm. The concentration of platelets in blood is 170 – 400 * 103 cells per µL. After 
their pinch-off of megacaryocytes in bone marrow they circulate in blood for 7 – 10 
days until they get catabolized in spleen and lungs. (Silbernagl 2007) Though they 
have no nucleus, therefore contain no nuclear DNA, platelets retain cytoplasmatic, 
megakaryocyte-derived mRNA which enables them to perform protein translation. 
(Gnatenko 2003) 
However, their main function is to perform haemostasis in case of injury. Thereby 
platelets get activated, aggregate and form the primary haemostatic thrombus (white 
thrombus). This leads to the activation of the coagulation cascade which further leads 
to formation and activation of thrombin that degrades fibrinogen to fibrin. Fibrin 
attaches to the primary haemostatic thrombus and forms the much more stable 
secondary haemostatic thrombus (red thrombus) together with the aggregated 
platelets. When the wound is healing, the red thrombus is slowly degraded by 
fibrinolysis. (Gawaz 2001) 
They also have an important immunological function because they can also act as 
cells of the innate immune system by activating leukocytes. (Weyrich 2004) 
Platelets have several inversions of the outer membrane that form the open 
canalicular system. This system increases the platelet surface by several folds. The 
canalicular system gives the platelets a sponge-like structure and proteins or ions are 
sponged into the canals. The increased surface area is important for a fast Ca2+ 
absorption to release the granula and activate the platelets. (Beck 2002) 
 
3.5. Blood plasma 
The main function of blood plasma is to transport nutrients. Plasma contains large 
amounts of metabolites, nutriments, electrolytes, vitamines and hormones dissolved 
in the aqueous solution (plasma) or attached to transporter proteins. 
In a HP diet changes in the plasma proteome, plasma amino acid concentrations and 
other plasma parameters like cholesterol, triglycerides, iron, zinc, vitamin B12 are 
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from great interest as the can be an indication for risk factors for cardiovascular 
diseases, osteoporosis or deficiency symtoms.  
 
3.5.1. Cholesterol and triglycerides  
The cholesterol status in a healthy individual is highly associated to its nutrition 
habits. Further the cholesterol status is an important parameter for the risk of 
cardiovascular diseases and therefore the measurement of these values is very 
important in an HP study.  
Cholesterol is a very important component of plasma membranes. It can be 
synthesized by the human body or supplemented by food. In blood cholesterol and 
triglycerides are transported by lipoproteins. Lipoproteins are differentiated between 
VLDL, IDL, LDL, HDL and Chylomicrons. They are classified by their physical and 
functional attitudes. All lipoproteins consist of lipids and proteins, so called 
Apolipoproteins that are transport proteins.  
LDL transports cholesterol into the tissue where it is needed as a component of cell 
membranes or for example as a precursor of steroid hormones. If there is too much 
cholesterol in the blood the LDL can attach to blood vessel walls and accumulate 
there, which increases the cardiovascular disease risk. Therefore LDL transports the 
so called “bad cholesterol”. HDL transports the “good cholesterol” because it 
transports excess cholesterol out of the tissue for degradation in the liver and 
excreted by the gall. For measurement of the cholesterol parameters in medicine not 
only the single LDL or HDL values are important, only the LDL/HDL cholesterol 
quotient gives meaningful information about the cholesterol status of the person 
since these lipoproteins should be in equilibrium.  
Triglycerides adapt very fast when nutrition habits are changed. The adaption of HDL 
and LDL to nutrition changes on the other hand is quite slow. They need about 6 
weeks to even out when nutrition is changed into a constant and healthy way. 
Papakonstantinou et al. for example showed in a 4 weeks HP study in type 2 
diabetes, obese individuals a significant decrease of triglycerides with HP diet. The 
total and LDL cholesterol on the other hand also decreased but there was no 
significant difference between the HP and the NP diet found. (Papakonstantinou 
2010b) Further it was shown in hypercolesterolemic rabbits that a consumption of soy 
yoghurt – which is plant protein – decreased the total cholesterol levels and 
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increases the HDL levels and thereby decreases the risk of cardiovascular diseases. 
(Cavallini 2009) 
 
3.5.2. Homocysteine, Folate and Vitamin B12  
Since the meat, fish milk products and eggs can derive the only sufficient vitamin B12 
source the measurement of this parameter is quite important in an HP diet study, 
where the protein derived form animal products. Folate and homocysteine are part of 
the same pathway like vitamin B12. (see figure 22, page70) To be able to find links all 
these parameters were also measured. 
Vitamin B12 is an enzyme that methylizes homocysteine to methionine that further is 
necessary for the methylation of lipids and DNA.  
High homocysteine levels are highly associated with cardiovascular diseases. 
(Omenn 1998) It was shown that an increased folate intake could decrease the 
homocysteine levels and thereby decrease the risk for cardiovascular diseases. 
(Boushey 1995) 
Referring to HP diet it was shown that an HP diet composed mainly by plants has a 
positive (decreasing) effect on the homocysteine levels whereas an HP diet deriving 
from animal sources has a negative effect. Further the homocysteine values 
correlated significantly with the folate but not with the vitamin B12 values. (Yakub 
2010) 
Further high homocysteine levels are associated with lower bone density. 
Krivosíková et al., showed that vegetarians have higher homocysteine levels and 
lower vitamin B12 levels that people who eat meat. Additionally they showed by 
correlations with bone markers, that vegetarians have a higher risk for osteoporosis 
correlating to hyperhomocystemia. (Krivosikova 2010) Clifton et al., on the other hand 
could not show a significant change of homocysteine or folate with a HP diet. Only 
the vitamin B12 levels increased with HP diet. (Clifton 2008) 
When reading the publications about the relationship between HP diet or rather diet 
in general and homocysteine, vitamin B12 and folate, the controversity of the results is 
surprising. It seems as if the regulation of these three factors by diet is multifactorial. 
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4. Aim of the study 
There is an increasing number of observational studies suggesting a positive role for 
protein in promoting optimal health at intakes beyond the Dietary Reference Intakes 
(DRI), such as weight management and satiety, sarcopenia, glucose homeostasis, 
and bone health. 
Many studies describe that a change in the protein diet influences muscle physiology 
as well as the composition of the muscle cells. 
The impact of an HP diet on certain proteomes in the body has so far not been 
analyzed. In this study we want to research the impact of an HP diet on muscle cells 
and therefore we are using platelets as a model. Human blood platelets are 
contractile and motile cells which share many features with muscle cells. Similarities 
between the contractile protein system of platelets and muscle have made the 
platelets a popular model for muscle disease. Platelet is a "minimuscle" with a protein 
contractile system (actin and myosin) similar to that of skeletal muscle. 
Furthermore there are several studies concerning changed protein diet and the 
homocysteine pathway. However, their results are very contradictorily. In this study 
we want to adduce the final evidence about the correlation of homocysteine, folate 
and vitamin B12 and a HP diet.  
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5. Study design 
5.1. Subject selection 
24 young healthy men were chosen for the study. (One of them dropped out because 
of flu) They had to be between 20 and 30 years old, non-smoking, had to have stable 
weights (i.e. ± 2 kg within the previous 3 months) and a body mass index between 
18.5 and 25. Exclusion criteria were the use of any medication on a daily basis, 
heavy physical exercise,smoking, chronic diseases or an illness in shoulder, arm or 
hand. The individuals had to guarantee to only consume foods and beverages 
provided by the Department of Human Nutrition, Faculty of Life Sciences, University 
of Copenhagen except for water and salt.  
 
5.2. Experimental design 
Before the study started there was a 3 days registration period where the individuals 
had to perform a weighted food diary and a physical activity diary. Afterwards a one-
week run-in period, where all individuals received a diet with average protein content 
of 1.5 g/kg (15 E %), was performed. Then the individuals were separated into two 
groups: a NP (normal protein) group and an HP (high protein) group. The NP group, 
containing 12 individuals, continued with the average protein content diet of 1.5 g/kg 
(15 E %) whereas the HP group, containing 11 individuals, received a high protein 
content diet with the double amount of the recommended protein content in daily 
nutrition of 3 g/kg (30 E %). This period lasted for three weeks. The protein primarily 
derived from meat and fish.   
 
Figure 2: Timetable of study period and protein amount expressed as a percentage in every 
step of the experiment 
 
3 day 
registration of 
food intake 
and physical 
activity 
1 week run-in 
period (15 E% 
protein diet) 
3 week NP diet (15 E % 
protein) 
3 week HP diet (30 E % 
protein) 
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During the study period the individuals received all foods and drinks from Department 
of Human Nutrition in Copenhagen. As mentioned before, the individuals were not 
allowed to consume any other food or beverages than they received from the 
department. The individuals had to consume lunch at the department under 
superstition on weekdays and the rest of the meals (dinner, snack, breakfast and 
drinks) were provided daily for takeaway and consumption at home. On Fridays the 
food for the weekend was provided as a package for taking home. The leftovers had 
to be brought back to the department for registration.  
 
5.3. Diets 
As mentioned before, there are two different diets applied in this study. In the run-in 
period, respectively the NP group a diet with 15 E % from protein per day was 
performed by the individuals. The HP group got twice the protein amount of the NP 
group, thus 30 E % protein per day. The diets varied in the ratio of protein to 
carbohydrate and had different compositions. The diets were matched for n-3 PUFA 
and dietary fiber content during the study period. 
 
 
Macronutrient composition of diets NP group HP group 
Protein 15 E % 30 E % 
Fat 30 E % 30 E % 
Carbohydrate 55 E % 40 E % 
Table 1: Diet composition of the NP group and the HP group expressed as a percentage.  
 
 
5.4. Measurements 
During the study period there were two time points where blood was taken from the 
individuals. The first time point (baseline) was at the end of the run-in period. The 
second time point (after treatment) was after the 3 weeks of intervention period, 
respectively at the end of the study period. After blood was taken, plasma and 
platelets were isolated and sent to Vienna.  
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Figure 3: timetable of study period and protein amount expressed as a percentage in every 
step of the experiment and time points that show the time point where blood was taken from 
the individuals. 
 
 
In Vienna platelet and plasma proteome was examined with 2D DIGE technique, 
plasma amino acids were measured with HPLC and plasma parameters 
(haptoglobin, vitamin B12, folate, cholesterol and triglycerides, albumin and 
homocysteine) were measured.  
3 day 
registration 
of food 
intake and 
physical 
activity 
1 week run-in 
period (15 E% 
protein diet) 
3 week NP diet (15 E % 
protein) 
3 week HP diet (30 E % 
protein) 
1st time 
point  
(baseline) 
2nd time 
point  
(after 
treatment) 
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6. Material and Methods 
6.1. Equipment and Material 
6.1.1. Blood collection  
• Hematology analyzer, MicroDiff 10, Beckman Coulter, USA and SYSMEX KX-
21N, Sysmex Digitana, CH  
• Vacutainer tubes, Greiner, Austria 
- Vacuette EDTA K3 tubes 
- Vacuette trisodium Citrate 3,8% 
6.1.2. Gel filtration 
• Refrigerated centrifuge, Universal 30 RF, Hettich 
• Columns for gelfiltration – Econo-Pac 15mm diameter, Bio Rad, USA 
• Sepharose 2B, Sigma-Aldrich, USA 
• D-PBS, Gibco, USA: 2.67 mM KCl, 1.47 mM KH2PO4, 137.93 mM NaCl, 8.1 
mM Na2HPO4 
• Urea buffer: 7 M urea, 2 M Thiourea, dissolve in ddH2O, add 1% Amberlite 
IRN-150L and stir for 1hour, filtrate and add 4% CHAPS, pH 8.5 at 4°C, 
aliquote and store at 4°C 
6.1.3. Affinity chromatography – ProteomeLab IgY-12 LC2 
• Affinity column: Proteome Lab IgY-12 LC2, Beckman Coulter, USA 
• Dilution buffer: 10 mM Tris-HCl, pH 7.4, 150 mM NaCl 
• Stripping buffer: 0.1 M Glycine-HCl, pH 2.5 
• Neutralization buffer (10 x): 1M Tris-HCl, pH 8.0 
6.1.4. Trichloacetic acid precipitation 
• Sample shaker, Labinco L46 
• TCA solution: 6.1 N TCA solution, 80 mM DTT 
• Acetone solution : acetone, 20 mM DTT 
6.1.5. Bradford measurement 
• ELISA reader, Wallac Victor2, Perkin Elmer, USA 
• Bradford protein assay: Coomassie Plus, Pierce, USA 
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6.1.6. CyDye sample labelling 
• CyDye DIGE Fluors (minimal dyes), 25-8010-65, GE Healthcare, USA: N, N-
dimethylformamide, anhydrous, 99.8 % (DMF), Sigma-Aldrich, Germany; 
CyDye stock solution: dissolve 5nmol of cyDye powder in 5µL of DMF 
• CyDye working solution: 0.45 µL CyDye stock solution, 2.0 µL DMF 
• Lysine stock solution: 10 mM Lysinmonohydrochloride 
6.1.7. Isoelectric Focussing  
• IPGphor, GE Healthcare, USA 
• IPG-Strips: Immpbiline Dry Strip Gels, GE Healthcare, USA 
• Rehydration buffer: 7 M urea, 2 M thiourea, dissolve in dH2O, add 1 % 
Amberlite IRN-150L and stir for 1 hour, filtrate and add 4 % CHAPS and some 
crumbs bromine phenolblue, aliquote and store at 4°C, before use add 1% 
Ampholyte and 70mM DTT 
6.1.8. Second Dimension Ettan DALT  six – SDS PAGE 
• Ettan DALTsix Electrophoresis Unit, GE Healthcare, USA 
• Typhoon TRIO – Variable Mode Imager, GE Healthcare, USA 
• Lower Tris Buffer (LTB) (4 x): 1.5 M Tris, dissolve in dH2O, pH 8.88, store at 
4°C 
• Acrylamide (30 %): 29.2 % acrylamide, 0.8 % N-N´ methylenbisacrylamide, 
dissolve in dH2O  
• N,N,N´,N´-tetramethylene-diamine (TEMED) 99 %, Sigma-Aldrich, Germany 
• Ammonium peroxidisulfate (APS), Merck, Germany 
• Running buffer (10 x): 250 mM Tris, 190 mM Glycin, 1 % SDS (add fresh 
before every experiment) 
• Molecular weight standard: Precision Plus Protein unstained standards, Bio 
Rad 161-0363, USA 
• Agarose sealing solution: 0.5 % Agarose, 0.1 % SDS, dissolve in 371 mM 
LTB, heat shortly in the microwave, add some crumbs bromine phenolblue, 
aliquote and store at –20°C 
• Equilibrationbuffer: 50 mM Tris, 6 M urea, 30 % Glycerol, 2 % SDS, dissolve in 
dH2O, pH 8.88, aliquote and store at –20°C, before use  add either 10 mg DTT 
per mL equilibrationbuffer or 25 mg iodacetamide per mL equilibrationbuffer 
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6.1.9. Silver staining – compatible for mass spectrometry 
• Scales - Sartorius, 4.8kg , Laboratory LC 4800 P 
• Analytical balance - Sartorius , Analytic AC 210 S 
• Fixing solution: 50% EtOH, 5% acetic acid   
• Washing solution: 50% EtOH  
• Sensitizing solution: 0,025% Na2S2O3    
• Silver solution: 0,15% silver nitrate  
• Developing solution : 0,04% Formaldehyde (37%), 2% Na2CO3 
• Stop solution: 5% acetic acid     
• Storage solution: 1% acetic acid  
6.1.10. Preparation for mass spectrometry 
• Speedvac 
• Trypsin: Roche 1418025 
6.1.11. High pressure liquid chromatography (HPLC) 
• HPLC-Glasspitzvials 1,1 cm³, Stölzle 58025 12 32 05 
• HPLC-Standardvials 2,0 cm³, Stölzle 58012 12 32 00 
• Bördelkappen zu HPLC-Vials, Stölzle 89540 11 00 04 
• MilliQ-plus Millipore water; Waters Millipore, Austria 
• O-phtaldehyde reagent 
• Buffer A 
• Buffer B 
• Acetonitrile: Merck 100 030, LiChrosolv  or  FLUKA 00687 
• Tetrahydrofurane: Merck 108 101, LiChrosolv  
• Methanol: Merck 106 009, LiChrosolv  
• 2-Mercaptoethanol: MERCK  15 433 or SIGMA M-6250 
• Sodium acetate: Merck 6264, Suprapur 
• 0,1M acetic acid: MERCK 100 063 
• Fluropa: SIGMA D-6518 
• 1M Boratbuffer (Fluoraldehyd): PIERCE 27 035 
• 5-Sulfosalicylsäure-Dihydrat: MERCK 100 691 
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6.2. Methods 
6.2.1. Preparation of plasma and platelet proteome samples 
6.2.1.1. Blood collection  
Peripheral venous blood samples were taken from antecubital vein. The first 7 mL 
were taken into EDTA vacutainer tubes with stasis. This blood sample was taken to 
compile a haemogram and to isolate plasma. Plasma isolation was performed by two 
centrifugation steps. First the whole blood was centrifuged at 2095 g at 4°C for 15 
minutes. Then 1 mL of the supernatant was centrifuged at 15000 g at 4°C for 10 
minutes. After the second centrifugation step the supernatant is purified plasma, 
which was aliquoted and stored at –80°C. The plasma  was later used for amino acid 
analysis, 2D DIGE gels and blood parameter analysis.  
Afterwards blood was taken without stasis into 4 citrate vacutainer tubes (9 mL). To 
separate thrombocytes from erythrocytes and leukocytes, the citrated whole blood 
was centrifuged for 20 minutes at 80 g at room temperature. On the bottom of the 
tube there is the erythrocyte layer. On top of the erythrocytes there are the 
leukocytes, and on the top of the tube there are the thrombocytes and plasma 
proteins. This yellow supernatant is called platelet rich plasma (PRP). PRP has to be 
removed very carefully to ensure, that none of the leukocytes are taken with it. The 
thrombocyte concentration was counted on the Blood Analyzer.  
 
6.2.1.2. Gel filtration 
To separate thrombocytes from plasma proteins, size exclusion chromatography was 
performed.  
Chromatography is a technique for separating molecules in a solution from each 
other. It is possible to disperse the analytes towards different parameters. In size 
exclusion chromatography for example molecules are separated by their size. In 
affinity chromatography certain proteins for example can be isolated because of 
antibodies that are fixed in the chromatography column. Other examples for 
chromatography are ion exchange chromatography, thin layer chromatography, high 
pressure liquid chromatography (HPLC) or gas-liquid chromatography. Though, the 
principle of all these methods is similar: There is always a stationary phase and a 
mobile phase. The stationary phase is a substance that is fixed and interacts with the 
substance that is supposed to be separated. The mobile phase is mixed with the 
analyte and is in motion. Every molecule has its substance specific retention time. 
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Retention time is the time a substance needs to go through a column. It depends on 
the affinity between the analyte and the stationary phase, the solubility in the mobile 
phase and its diffusion properties.  
In this study size exclusion chromatograph was performed to separate platelets from 
plasma proteins, since thrombocytes are considerable bigger and thereby eluted 
faster than plasma proteins, which invade in pores of sepharose.  
Sepharose-2B that was stored in ethanol, PBS and frits were degassed in a vacuum 
desiccator for 45 minutes. Columns were filled with 19 mL of Sepharose-2B. When 
the sepharose was condensed to the 11 mL mark of the column, the frit was placed 
at the top of the sepharose. The column was washed twice with PBS to remove the 
ethanol left in the sepharose. The frit avoids the column running dry and assures 
even application of PRP.  
1 mL of PRP was applied onto column. When it was infiltrated totally, 2.5 mL PBS 
were applied. Thrombocytes were eluted with 1.5 mL PBS and collected. The eluate, 
that is highly cloudy because of the thrombocytes, is called gel-filtered platelets 
(GFP). The concentration of thrombocytes in GFP was counted on a Blood Analyzer. 
 
6.2.1.3. Plasma sample pools 
For EDTA plasma proteome analysis sample pools were used. 4 (once 3) Individuals 
were pooled in one group. The pooled individuals had to be in the same experimental 
group and in the same clinical investigation day.  
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Baseline After treatment 
  
sample 
(individuals) pooled samle 
sample  
(individuals) pooled samle 
02-K101-01 03-K101-01 
02-K101-03 03-K101-03 
02-K101-07 03-K101-07 
02-K101-08 
SV1 
03-K101-08 
SN1 
02-K101-10 03-K101-10 
02-K101-11 03-K101-11 
02-K101-13 03-K101-13 
02-K101-14 
SV2 
03-K101-14 
SN2 
02-K101-18 03-K101-18 
02-K101-21 03-K101-21 
02-K101-24 03-K101-24 
15
 
E%
 
m
ea
t 
02-K101-25 
SV3 
03-K101-25 
SN3 
02-K101-02 03-K101-02 
02-K101-04 03-K101-04 
02-K101-06 03-K101-06 
02-K101-12 
SV11 
03-K101-12 
SN11 
02-K101-15 03-K101-15 
02-K101-17 03-K101-17 
02-K101-19 03-K101-19 
02-K101-20 
SV22 
03-K101-20 
SN22 
02-K101-22 03-K101-22 
02-K101-23 03-K101-23 
30
 
E%
 
m
ea
t 
02-K101-26 
SV33 
03-K101-26 
SN33 
Table 2: List of individual samples that were pooled for plasma proteome analysis. 
 
 
6.2.1.4. Affinity chromatography – ProteomeLab IgY-12 LC2  
For pasma 2D DIGE gels it is important to remove the high abundant proteins from 
the plasma. Otherwise the high abundant proteins would cover the low abundant 
proteins on the gel with their stron signal and a proteome ananlysis would not be 
possiple. Therefore we used affinity chromatography after pooling the EDTA plasma 
samples. 
In affinity chromatography receptors, antibodies or enzymes are fixed in the 
stationary phase. When a protein alloy is applied on the column, some proteins can 
bind specifically and the rest is flushed out of the column. With an eluate the affinity 
between stationary phase and protein can be reduced and these specific proteins 
can also be removed from the column. This is a possibility to filter one protein of 
interest out of a mixed sample.  
In this study the ProteomeLab IgY-12 LC2 column is used. It can remove 
simultaneously twelve highly abundant plasma proteins, namely human serum 
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albumin, IgG, α1-antitrypsin, IgA, IgM, transferring, haptoglobin, α1-acid glycoprotein 
(orosomucoid), α2-macroglobulin, HDL (apolipoproteins A-I and A-II) and fibrinogen. 
As ligands affinity purified avian (IgY) antibodies are used. The column has a 
capacity of about 1875 µg of proteins. The respective yields of depleted proteins 
according to the manufacturer are 200 µg. Thus 11 % of the total amount of applied 
proteins should be recovered in the depleted protein fraction.  
As a pre-treatment before every run the column has to be equilibrated for 20 minutes 
with 1x dilution buffer at a flow rate of 1 mL/min. In the meantime the sample can be 
prepared. 25 µL of plasma sample are mixed with 100 µL 1x dilution buffer and 
centrifuged in filter tubes for 1 minute at 10.000 rpm to remove any particles from the 
sample. Then the 125 µL diluted and pooled (see chapter 4.2.1.3) plasma sample 
can be loaded on the column at a flow rate of 0.1 mL/min. 600 µL of 1x dilution buffer 
are applied on the sample at a flow rate of 0.1 mL/min. The 600 µL are the volume 
that is needed to get the sample right in front of the entrance of the column. While still 
soaking up dilution buffer with a flow rate of 0.1 mL/min the 1.5 mL flow-trough are 
discarded. The next 1.5 mL of the flow-trough contain the sample and are collected in 
an Eppendorf tube with a flow rate of 0.2 mL/min. The column in washed with 6 mL of 
dilution buffer at a flow rate of 1 mL/min and afterwards the bound proteins are eluted 
with 35 mL stripping buffer. To neutralize the pH after elution the column is treated 
with 6 mL neutralization buffer. If there is another sample to run the column is 
equilibrated with dilution buffer for 20 minutes again, otherwise the column is washed 
with 6 mL dilution buffer (incl. 0.02 % NaN3) and stored at 4°C. Under proper 
conditions the IgY micro beads should be reusable for 100 times.  
 
6.2.1.5. Trichloacetic acid (TCA) precipitation   
Both the gel-filtrated platelets (GFP) and the plasma samples after affinity 
chromatography are TCA pecipitated.  
Therefore 500 mL of ice-cold TCA solution were mixed with 1.5 mL of GFP 
respectively plasma. The mixture was stored 60 minutes at 4° C. Cells were lysed 
and proteins precipitated. After one hour the precipitate was centrifuged for 10 
minutes at 10.000 g at 4°C. A white protein pellet was formed. The pelled was 
washed four times with ice-cold acetone solution. It is possible to store the samples 
at –80° C at this step of preparation and go on wit h the procedure any other day. The 
pellet was dried by air evacuation and resolubilized in denaturizing urea buffer by 
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shaking over night at 4° C. The next day the soluti on was centrifuged for 10 minutes 
at 10.000 g at 4° C, aliquoted and stored at –80° C . 
 
6.2.1.6. Bradford measurement 
Bradford method was used for protein concentration measurement after TCA 
precipitation. A BSA (bovine serum albumin) dilution series in PBS with seven 
different concentrations (0 – 0.3 mg/mL) was used as standard (see table 1). 
 
 
 conc. [mg/mL] µL BSA [1mg/mL] µL PBS 
S1 0 0 950 
S2 0.05 50 900 
S3 0.10 100 850 
S4 0.15 150 800 
S5 0.20 200 750 
S6 0.25 250 700 
S7 0.30 300 650 
Table 3: BSA standard dilutions, aliquots to 190 µL and stored at –20°C 
 
 
190µL of each standard were mixed with 10µL of the used sample buffer. Thereby 
interfering influences of the sample buffer should be compensated. The sample was 
diluted 1: 20 in PBS. 20 µL of every standard dilution and sample were applied three 
times on a 96-well microtiter plate. 200 µL of Bradford Reagens were applied on 
standards and sample as fast as possible. After 5 minutes the absorption was 
measured in an ELISA-reader at a wavelength of λ = 595 nm.  
The mean value of all three same samples and standards was calculated and 
multiplied with the dilution factor. A standard curve was created where the values of 
the sample were inserted to calculate the protein concentration.  
 
6.2.1.7. Assembling of an internal standard 
After concentration measurement two internal standards are prepared: one internal 
standard for the ETDA plasma DIGE analysis and one for the platelet proteome 
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ananlysis. The internal standard is of prime importance to minimize the technical 
variance. It consists of the same amount of protein of each sample in the study. 
The internal standard of the platelets samples was made of 60 µg of each sample. 
Since the platelet internal standard was not only used for this study but also for 
another study, the internal standard consisted of the high protein diet study samples 
as well as of 105 samples from another study. 
The internal standard for the plasma proteome analysis was made of 15 µg of each 
sample.  
After the pooling of the samples to prepare an internal standard, Bradford was 
performed again, to know the exact protein concentration of the internal standard. 
 
6.2.2. 2D – differential gel electrophoresis (DIGE) 
Both the platelets and the plasma proteome were analysed with 2D DIGE. Due to 
CyDye labelling of the samples it is possible to compare two smples with each other 
on one DIGE gel. Because of the internal standard that is applied on every gel it is 
also possible to compare samples that are on different gels. 
The first step in 2D DIGE is the sample labelling. Afterwards the first dimension is run 
followed by the second dimension.  
 
6.2.2.1. CyDye sample labelling 
Samples were labelled immediately before IEF was performed. One sample was 
labelled with Cy 5, the comparing sample with Cy 3 and the internal standard with Cy 
2 and focussed together on one IEF strip. The dyes bind covalent by amid bond 
between their NHS group and the ε-amino group of the lysines of the proteins in the 
sample. This technique is described to be a minimal labelling technique, because the 
dye constitutes the limiting factor. Only 1 – 2 % of all the lysines are labelled. The 
CyDyes cause no change of the isoelectric point of the proteins and only increase 
molecular weight by about 500 Da. The labelling reaction is stopped by an overspill of 
lysine added after 40 minutes.  
Samples were centrifuged for 10 minutes at 10 000 g at 4° C before use to remove 
possible precipitates. 17 µg sample were mixed with 0.35 µL CyDye working solution 
and incubated on ice for 40 minutes in the dark. 0.5 µL lysine [10 mM] were added to 
stop labelling reaction and incubated on ice for 10 minutes in the dark. Cy 5 and Cy 3 
samples and Cy 2 internal standard were pooled.  
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6.2.2.2. Isoelectric Focussing (IEF) pH 4 – 7 
Isoelectric focussing serves for separating proteins with the isoelectric point by 
applying voltage. Thereby IPG-strips, a gel matrix with immobilized pH gradient on a 
plastic carrier, are used. The strips have to be expanded before use, because they 
are dried. Proteins that are supposed to be separated are stored in urea buffer.  
The sample is infiltrated into the strip by passive rehydration. The pooled CyDye 
samples were mixed with 70 mM DTT and 1% ampholyte pH 4 – 7 and filled up to 
450 µL with rehydration buffer. The rehydration mix was applicated to IPG strip 
holders, a special ceramic container with electrodes on each end, and IPG-strip (24 
cm) was applied with the gel layer downwards. The sample has to be arranged even. 
To prevent running dry, it was overlaid with 2 mL oil. The strips were reswelled for 12 
hours.  
Immediately before IEF was started, small filter pads soaked in rehydration buffer 
with 70 mM DTT and 1 % ampholyte pH 4 – 7 were put between electrodes and IEF 
strip. Then IEF was started. (see table 4) 
 
 
Step  Voltage [V] Time [h] 
1 Step-n-Hold 200 0:01 
2 Step-n-Hold 10 0:01 
3 Gradient 200 2:00 
4 Step-n-Hold 200 2:00 
5 Step-n-Hold 300 2:15 
6 Gradient 5000 7:30 
7 Step-n-Hold 5000 2:20 
8 Step-n-Hold 500 3:00 
Table 4: IEF parameters for 24 cm IEF strips pH 4 - 7; 50 µA/strip at 20°C 
 
 
Step 8 has only been a safety step, for preventing the strip being without voltage 
when the IEF was over. When step 7 was finished the strips were stored at –80°C 
until second dimension was performed.  
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6.2.2.3. Isoelectric Focussing (IEF) pH 6 – 9 
Separating proteins from pH 6 – 9 works by applying the sample by “cup-loading” on 
the strip. First the strip has to reswell for 10 hours in rehydration buffer with 150 mM 
DTT and 2 % ampholyte pH 6 – 9. Therefore the strip is laid in a reswelling tray with 
the gel layer downwards and overlaid with 2 mL oil. For applying the sample after 
rehydration, the strip is put into strip holder specially constructed for cup loading with 
the gel layer upwards. On both electrodes at the ends of the strip holders, filter pads 
are placed exactly at the end of the gel layer of the strip. The filter pad at the anode 
is dipped into rehydration buffer before applying, whereas the one at the cathode is 
soaked with 175 µL rehydration buffer with 3.5 % DTT and 2 % ampholyte. During 
isoelectric focussing, the DTT migrates from cathode to anode. To avoid the cathode 
end of the strip being without DTT, the filter pad is soaked in this special mixture.  
Electrodes are put on the filter pads and the “cup” is placed right in front of the 
anode. For not drying-out the strip is overlaid with 4.5 mL oil. The dyed and pooled 
samples are filled up with rehydration buffer to 55 µL, 150 mM DTT and 2% 
ampholyte pH 6 – 9 are added. The sample mix is transferred into the “cup” and 
isoelectric focussing is started. (see table 5) 
 
 
Step  Voltage [V] Time [h] 
1 Step-n-Hold 300 0:01 
2 Step-n-Hold 300 3:00 
3 Gradient 1400 6:00 
4 Step-n-Hold 1400 8:00 
5 Gradient 3500 3:00 
6 Step-n-Hold 3500 2:20 
7 Step-n-Hold 500 3:00 
Table 5: IEF parameters for 24 cm IEF strips pH 6 - 9; 50 µA/strip at 20°C 
 
 
Step 8 has only been a safety step, for preventing the strip being without voltage 
when the IEF was over. When step 7 was finished the strips were stored at –80°C 
until second dimension was performed. (Zellner 2005) 
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6.2.2.4. Second Dimension Ettan DALT  six – SDS PAGE 
After separating the proteins by their pI with isoelectric focussing the proteins have to 
be separated by their molecular weight. This is done in a polyacrylamide matrix in a 
24 cm SDS (Natriumdodecylsulfate) gel.  
During sample preparation SDS was added which results in the proteins being 
negatively charged. Further DTT was added to the sample which causes destruction 
of the secondary and tertiary structures of the proteins. By applying voltage the 
proteins migrate depending on their molecular weight respectively on the length of 
the polypeptide chain through the gel towards the anode with different velocity. 
Bigger proteins need more time to cover the same distance than smaller proteins 
would need.  
With Ettan DALT six system it is possible to prepare and run six gels at the same 
time. For gel casting low fluorescence glass plates are used. At first the glass plates 
are cleaned with double distilled water and high pressure oxygen to minimize 
contamination of the sample and to get rid of dust particles that could have 
fluorescent abilities and complicate further analysis. To minimize variations in the gel 
preparation the acryl amide solution was always prepared freshly and filtered before 
usage. After degassing the gel solution (see table 6), APS and TEMED were added 
under gentle mixing and the gel solution was filled into the gel casting system till 
about 5 mm underneath the glass plates. In 2D electrophoreses instead of using 
stacking gel the IPG strip is directly applied onto the resolving gel and therefore the 
area to keep free for the strip can be quite small. Afterwards 2 mL of water-saturated 
butanol are applied on each gel and the gel mixture is let polymerise for 1 hour. For 
the platelet proteome analysis a 11.5 % polyacrylamide gel was used and for the 
EDTA plasma analysis a 9 % polyacrylamid gel was used. 
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Resolving gel (26 cm x 20 cm, 1 mm thick) 
Solution 11.5 %  9 %  
LTB (4x) pH 8.88 125 mL 125 mL 
Acrylamide (30 %) 193 mL 150 mL 
SDS 0.5 g 5 mL (10% SDS) 
Aqua dest. 178 mL 220 mL 
Degas for 1 hour 
APS (10 %) 3.75 mL 3.75 mL 
TEMED 165 µL 165 µL 
Table 6: Preparation of 26 cm resolving gels for 2D-DIGE containing 11.5% or 9% acryl 
amide 
 
 
During polymerisation the running buffer is prepared and cooled down to 10°C in the 
electrophoresis chamber. The polymerised gels and glass plates are taken out of the 
pouring chamber, polyacrylamide remains on the outside of the glass plates are 
removed with distilled water and the top of the gel is washed twice with running buffer 
to get rid of the butanol. To prevent the gels from running dry they are overlaid with 
running buffer until the IEF strips are ready to be applied. 
Before the IEF strips are applied, two equilibration steps must be performed. At first 
the strips are gently shaked in equilibration buffer containing DTT for 20 minutes. 
DTT reduces disulfide bonds and unfolds the protein totally. Afterwards the strips are 
shaked in equilibration buffer containing iodacetamide for 15 minutes. Iodacetamide 
removes excess DTT and alcylates the sulfhydryl groups.  
After equilibration the strips are applied on the gels whereas the lower pH rage is 
supposed to be on the left side. A small filter pad soaked with 3 µL of molecular 
weight standard is placed at the end of the strip at the right side. Strip and filter pad 
were coated with agarose sealing solution and remaining air bubbles between the 
strip and the gel are removed. The gels are put into the Ettan DALT running chamber 
and the Upper Buffer Chamber, which was filled with the remaining cool running 
buffer, was applied on top of them. For the electrophoretic separation an overnight 
protocol was used (see table 7). 
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Voltage [V] Time [hours] 
30 1,5 
50 3 
110 16 
Table 7: Setting for gel electrophoresis of 26 cm polyacrylamide gels. The run was stopped 
when the tracking dye bromphenol blue had just run out of all gels. 
 
 
On the next day, the gels were scanned in the Typhoon TRIO scanner. After a 
prescan laser intensity (PMI) was adapted to the gels and then the scan was started. 
The gels were scanned inside the glass plates to prevent warpage. Therefore DIGE 
glass plates are made from non-fluorescent glass. After scanning the 2D DIGE gels 
can be analyzed with the DeCyder software.  
 
6.2.3. 2D DIGE gel analysis – DeCyder 2D Software, version 6.5 
DeCyder 2DTM software allows detection, quantification and statistical analysis of 
Ettan DIGE system gels. Before statistical analysis is possible, several steps are 
performed including spot detection, background subtraction, in-gel normalization and 
gel-to-gel matching. After preparing the gels in the DIA (Differential In-gel Analysis) 
tool 300 to 400 spots were matched manually in the BVA (Biological Variation 
Analysis between gels) tool. Automated spot matching was performed and afterwards 
corrected manually in some gel areas. Statistical analysis was also performed in the 
BVA tool.  
For gel to gel matching one image has to be assigned as master image to which all 
other spot maps will be matched sequentially. In DeCyder one gel image is referred 
to one spot map, which can either be a Cy 2, Cy 3 or Cy 5 image. To determine the 
master gel, all gel images were looked at to find the one with the best labeling and 
separation quality.  
The optimum number of spots for spot detection was also determined in the DIA tool. 
Starting from these calculations the estimated number of spots was assessed to be 
2500 for spot detection in pH 4 -7 gels. In pH range 6 -9 the number of spots for spot 
detection was 2800. 
In the DIA module spots are detected and quantified. Therefore, a cumulative image 
of the three individual CyDye gel images is used to ensure that all spots are included. 
After spot detection the DIA algorithms calculate spot protein abundances for each 
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image, which are expressed as ratios to compare the expression levels of 
corresponding spots. Therefore the spot volumes have to be calculated first. The spot 
volume (V) is defined as the sum of pixel intensity within the spot boundary and is 
always given with background subtracted (Vg). Background subtraction is performed 
by excluding the lowest tenth percentile pixel value on the spot boundary from all 
other pixel values within the spot boundary. The spot volume then corresponds to the 
sum of these corrected values. 
Spot ratios are calculated as follows, volume of sample image spot (Vg(S)) over 
volume of internal standard image spot (Vg(IS)). See formula 1. 
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Ri ... spot ratio; indicates change in spot value between two images 
i ... refers to all spots that are included in analysis 
 
 
Then all ratio values are logarithmised and combined to create a histogram. Since 
the majority of protein spots should have an unchanged expression, the main peak of 
the histogram should be centered on the value zero. Though, usually the main peak 
of the raw log volume ratios is not centered on zero and therefore normalization is 
necessary. 
Intra-gel normalization is done by fitting a Gaussian curve to the main peak (C) of the 
raw log volume ratio histogram to calculate the normalization factor. Any values 
below 10 % of the main peak height are excluded from the model curve fitting 
procedure. The normalization factor is represented by the centre of the resulting 
model curve (C’). The volume values in the standard spot maps (Vg(IS)i) are then 
multiplied by 10^C’. See formula 2. 
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For automated matching in the BVA – after matching 300 to 400 spots manually – a 
pattern recognition algorithm, that matches one single spot in the one gel to a single 
spot in another gel based on its neighboring spots, was used. 
The normalization procedure between gels in the BVA module is based on the 
integration of an internal standard sample on each gel. This standard image is then 
used for inter-gel normalization. The intra-gel normalized volume (Vg(IS)inorm) from 
the DIA workspace is divided by its corresponding procedure in BVA is generally the 
same as in the DIA module, but as primary image the standard image (IS) is used in 
the calculations. The normalized volume ratios are also referred to as standardized 
abundance (SA). See formula 3. 
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As a result of this analysis a table, called appearance table, is created in the BVA 
module, in which the SA-values of each protein spot on each spot map are 
contained. The logarithm of the normalized volume ratios also referred to as 
standardized log abundance (log SA) is used for further statistical analysis. ( 2010; 
Michlmayr A. 2007) Statistical analysis was also performed in BVA. Paired and 
unpaired Student t-test were calculated for all spots in all possible combinations of 
the experimental groups and time points.  
 
6.2.4. Silver staining – compatible for mass spectrometry 
In the DeCyder software a statistical analysis of all spots on the gels can be 
performed. To identfy spots of interest the gels must be dyed and the interesting spot 
has to be analyzed with mass spectrometry. Therefore after scanning the gels, the 
gels were taken out of the glass plates and shaked in fixing solution for 20 minutes. 
Without fixing solution the proteins would diffuse in the gel. Then the gels are washed 
with washing solution for 10 minutes to get rid of the acetic acid that would have a 
bad influence on the silver stain. After washing with water for 10 minutes the gels are 
incubated with water overnight.  
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At the next day the gels were incubated with sensitizing solution for 3 minutes exactly 
and after washing twice with water for 1 minute the gels were shaked in silver 
solution for at least 45 minutes. The next two washing steps (1 minute in water) 
minimize the background of the silver stain. The gels are incubated in developing 
solution until the intensity of the stain is as desired. The developing is stopped with 
stop solution 5 minutes 3 times. The gels can be shrik-wrapped and stored until 
preparation for mass spectrometry is done after incubating the gels in storage 
solution over night.  
 
6.2.5. Preparation for mass spectrometry 
After silverstaining the gels, the spots of interest are cut out of the gel with a scalpel. 
4 to 5 spots, differing in molecular weight and isoelectric point in a great amount, 
were pooled in one reaction tube. After washing the spots with 1 % acetic acid 
solution for about half an hour, 500µl 15 mM K3Fe(CN)6 / 50 mM Na2S2O3 is added to 
the spots and destained for 2-3 minutes. The supernatant is discarded and spots are 
shaked with 500µl 50% Methanol / 40% H2O / 10% CH3COOH for 4 times for five 
minutes to wash out the destaining reagent. For adjusting the right pH, the spots are 
washed in 500 µL 50 mM NH4HCO3 (pH > 7.5) for 5 minutes. Disulfide bonds are 
reduced during an incubation of 50 mM NH4HCO3 (pH > 7.5) and 10 mM DTT for 30 
minutes at 56° C, followed by a washing step in 500  µL 50 mM NH4HCO3 (pH > 7.5) 
for 5 minutes. For alkylation of the disulfide bonds the spots are incubated in 50 mM 
NH4HCO3 (pH > 7.5) and 50 mM Iodacetamide for 20 minutes at room temperature in 
the dark. After another washing step with 50 mM NH4HCO3 (pH > 7.5) the 
supernatant is discarded and spots are incubated with 100 µL Acetonitril until the 
spots have an homogen white color. Supernatant is discarded and the pieces of gel 
are dried in the speedvac for 20 minutes. Per spot 5 µL trypsin solution is applied and 
incubated for 20 minutes on ice. Per spot 10 µL 50 mM NH4HCO3 (pH > 7.5) is 
applied and incubated at 37°C over night.  
At the next day the tubes are centrifuged for 1 minute at 1000 rpm and then 20 µL 50 
mM NH4HCO3 (pH > 7.5) are applied and incubated for 30 minutes. After 15 minutes 
in the ultrasound bath the supernatant is transferred into a silicon covered reaction 
tube and 20 µL of 5 % formic acid 50 % acetonitrile is applied to the gels. After 10 
minutes in the ultrasound bath the supernatant is transferred into the silicon covered 
reaction tube and 20 µL of 5 % formic acid 50 % acetonitrile is applied to the gels. 
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After 10 minutes in the ultrasound bath the supernatant is transferred into the silicon 
covered reaction tube and the volume of the supernatant is reduced to 20 µL in the 
speedvac. Samples where either stored at -80 °C or brought to the mass 
spectrometry directly.  
 
6.2.6. High pressure liquid chromatography (HPLC)  
For the EDTA plasma amino acid analysis HPLC was performed. HPLC is another 
type of chromatography and works in principle in analogous manner like all other 
chromatographies described before. There is a stationary phase fixed in the column 
and a mobile phase mixed with the analytes. Though with this method it is not only 
possible to separate substances it is also a technique for quantification and 
identification of analytes with the help of standards. 
 
 
 
 
 
Figure 4: Diagrammatic assembly of a simple HPLC basic system. A, B, C, D are the 
reservoirs filled with mobile phase or analytes. 
 
 
Figure 4 shows a diagrammatic assembly of a simple HPLC system. At the beginning 
there are reservoirs filled with the mobile phase, the eluate or the analyte. With the 
injector a defined amount of analyte is added to the mobile phase flow. The column is 
packed with anorganic porose microparticles and warmed up to a specific 
temperature with the thermostat. The thermostat is important to achieve good 
reproducibility of retention times, since retention factors are dependent on 
temperature. The pump forwards the mobile phase with certain velocity through the 
chromatography column. In the detector the different fractions are analyzed. There 
are different kinds of detectors, for example UV detectors, fluorescence detectors, 
electrochemical detectors or mass spectrometer with ESI ionisation. All these 
detectors are concentration dependent. The data system registers the signals, 
converts them from analogue to digital and saves them on the computer.  
In this experiment reversed-phase chromatography was used which means that the 
stationary phase is nonpolar and elution force decreases with increasing polarity. 
A   B 
 
C   D 
pump injector 
   thermostat 
column detector data system 
  
39 
SiO2 Particles were used as stationary phase that were derivatized with 
octadecylsilan (ODS) to decrease retention times that would have been much too 
long otherwise. Further the mobile phase was a polarity gradient in this experiment to 
achieve better separation. Separation was done at 22° C and signals were detected 
with a fluorescence detector. Fluorescence detectors irradiate analyte molecules with 
light, the molecules get activated and emit light and after going through several filters 
and fences the molecules can be identified and quantified because of the wavelength 
and the intensity of the emission.  
20 µL of sulfosalicylic acid (30 %) containing 1 mM β-(2-thienyl)-DL-alanine, used as 
internal standard, were added to 200 µL EDTA plasma for deproteinisation. After 
incubating the samples for 30 minutes at -20°C they  were brought to room 
temperature again and centrifuged for 5 minutes at 15000 g. The supernatant was 
used for analysis.  
The column was pre – derivated with o-phtalehyde reagent (OPA) for one minute. 7 
µL of the plasma supernatant were mixed with 800 µL destilled and deionisized water 
and 7 µL of this dilution were injected onto the column by a Spark Triathlon 
autosampler. The particle column, packed with 3 µm big SiO2 – ODS C18, had a size 
of 150 mm x 3 mm and the chromguard column sized 10 mm x 3 mm. Separation 
was performed at a temperature of 22° C using a ste p gradient of buffer A and buffer 
B at a flowrate of 0.5 mL/min. Detection was obtained with a fluorescence detector 
with an excitation wavelength of 330 nm and an emission wavelength of 440 nm. 
Data acquisition and evaluation were carried out by Beckman System Gold software.  
 
6.2.7. Go/NoGo test 
The Go/NoGo test is a complex reaction time test. Subjects see geometric shapes in 
different colors in increasing frequency and have to press or not press a button with 
the left or the right hand, depending on the shape they see. The frequency stresses 
the subjects. The wrong or missing reactions are measured and are a dimension for 
the reaction time of the subjects. (Zimmerman 2007) 
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7. Results 
7.1. Influence of High Protein diet on platelet proteome 
To get an overview if a change in the dietry protein amount intake has an influence 
on the basic molecular composition of platelets a proteome analysis was done by 2D 
DIGE in the pH ranges 4-7 and 6-9.  
Significant protein expression changes between the platelet proteomes of the NP and 
the HP groups were calculated by student t-test. A HP dependent diet effect was 
evaluted with three different calculation steps: The HP protein profile was mached 
within the study group by comparing the expression levels of baseline and after 3 
weeks intervention time (1), the HP and the NP proteomes of the two study groups 
were compared after 3 weeks intervention time (2) and the HP proteome after 3 
weeks and the NP proteome at the baseline (3) were compared.  
Additionally the NP group was compared at the baseline and after 3 weeks 
intervention time (4), the HP and the NP groups were at the baseline (5) and the NP 
group at the after treatment time point and the HP group at the baseline (6) were 
compared. However the change in the diet of the NP group may have an influence on 
platelet protein composition. 
Moreover also a substantial number of false positives may accumulate at the 0.01 
confidence level because 1% of sample differences will be significant by change 
even if no changes in protein expression exist between the two samples 
Therefore proteins that happened to be significant in the t-tests of 4-6 are supposed 
to be not HP related protein expression changes. 
 
Figure 5: Diagram of calculation groups for statistical analysis to find HP diet associated 
changes (1-3) or false positive changes (4-6).  
NP group  
HP group  
NP group  
HP group  
baseline  after treatment  
5
6
3
2
4
1
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If the same individuals were compared within the same treatment group, paired 
student t-test was made. Unpaired t-test had to be calculated for comparison across 
the treatment groups (of the HP and NP group). Additionally an unpaired t-test was 
calculated within a treatment group to have an adequate comparison of the 
significant changes also between the two different treatment groups. The significant 
range was defined p < 0.05 and the number of significant events was counted. Not all 
the significant events derived from proteins. Some significant spots derived from 
artefacts, too low abundant or badly separated protein. These events were also 
counted. To have also an overview of another reason for false positive events the 
percentage of well defined protein spots of all significant events was calculated. 
Significantly changed spots, that were associated with HP and NP diet, were 
analysed with mass spectrometry. 
 
7.1.1. High protein diet related platelet protein changes in 2D DIGE gels – 
pH 4 - 7 analysis 
In average 2075 ± 163 spots are counted across all individual acidic 2D DIGE gels 
and the average number of matched spots to the master gel is 1412 ± 85.   
 
Table 8: Number of significant events, significant spots and artefacts for all possible 
combinations of groups and time points. Percentage of significant protein spots of all 
significant events. Numbers (1-6) describe the calculation groups in statistical analysis (see 
figure 5)  
 
 
The number of significant spots is not exactly the same when calculated with paired 
or unpaired t-test in both, the HP and the NP diet group. Though, the significant spots 
are always the same except one change in the HP group and two changes in the NP 
group. The percentages of clearly defined protein spots from all significant events 
across the calculation groups are between 74 % and 82% apart from two exceptions. 
When comparing the two after treatment groups, the percentage of significant protein 
is 57 % and when comparing the two groups at the baseline the percentage of 
 
1 
paired 
t-test 
1 
unpaired 
t-test 
2 
unpaired 
t-test 
3 
unpaired 
t-test 
4 
paired 
t-test 
4 
unpaired 
t-test 
5 
unpaired 
t-test 
6 
unpaired 
t-test 
significant events 248 248 53 302 338 335 50 420 
protein spots 203 202 30 224 265 264 31 336 
artefacts 45 46 23 78 37 71 19 84 
% protein 82 81 57 74 78 79 62 80 
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significant protein is 62%. At figure 6 the total significant events, the number of 
artefacts and the number of significant proteins are shown across all possible 
combinations of comparison between the two study groups. 
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Figure 6: Number of HP and NP-related protein spot changes in pH range 4-7: All possible 
combinations of groups and time points were calculated to get an overview of possible 
interference of the standardized nutrition and grouped individuals. Numbers (1-6) describe 
the calculation groups in statistical analysis (see figure 5) 
 
 
7.1.2. High protein diet related platelet protein changes in 2D DIGE gels – 
pH 6 -9 analysis 
In average 2075 ± 163 spots are counted across all individual alkaline 2D DIGE gels 
and the average number of matched spots to the master gel in pH range 6-9 is 
1072.39 ± 65.40. 
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Table 9: Number of significant events, significant spots and artefacts for all possible 
combinations of groups and time points. Percentage of significant protein spots of all 
significant events. Numbers (1-6) describe the calculation groups in statistical analysis (see 
figure 5) 
 
 
The number of significant spots is not exactly the same when calculated with paired 
or unpaired t-test NP diet group. Though, the significant spots are always the same 
except three changes. The percentages of significant proteins from all significant 
events across the calculation groups are between 72 % and 86% apart from one 
exceptions. When comparing the two after treatment groups, the percentage of 
significant protein is 50. At figure 7 the total significant events, the number of 
atrefacts and the number of significant proteins are shown. 
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Figure 7: Number of HP and NP-related protein spot changes in pH range 6-9: All possible 
combinations of groups and time points were calculated to get an overview of possible 
interference of the standardized nutrition and grouped individuals. Numbers (1-6) describe 
the calculation groups in statistical analysis (see figure 5) 
 
  
1 
paired 
t-test 
1 
unpaired  
t-test 
2 
unpaired 
t-test 
3 
unpaired 
t-test 
4 
paired 
t-test 
4 
unpaired 
t-test 
5 
unpaired 
t-test 
6 
unpaired 
t-test 
significant events 104 104 44 265 195 197 43 132 
Protein spots 89 89 22 223 167 169 31 95 
artefacts 15 15 22 42 28 28 12 37 
% protein 86% 86% 50% 84% 86% 86% 72% 72% 
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7.1.3. Corrected Platelet proteome analysis – elimination of supposed 
plasma protein contamination in in platelet proteome analysis 
After the identification of protein identities by mass spectrometry of significantly 
changed proteins related to HP and NP diet it was conspicuous that mainly plasma 
proteins were significantly increased in the platelet proteome in the HP as well as in 
the NP study group. 
Further it was conspicuous that several proteins that were previously observed as 
platelet proteins with very low biological variance (Zellner 2009) were decreased in 
platelet samples of HP as well as NP in the after treatment measurements compared 
to the baseline (table 10a and 10b).  
 
pI range 4-7   
Protein Name SwissProt Acc.No. CV 
% change 
HP diet 
paired t-test 
HP diet 
14-3-3 protein gamma P61981 0,084 -6 0,019 
Peroxiredoxin-6 P30041 0,086 -1 0,65 
Growth factor receptor-bound protein 2 P62993 0,088 -4 0,31 
F-actin capping protein beta subunit  
(Cap Z beta) P47756 0,088 -4 0,15 
Serine/threonine-protein phosphatase 
PP1-alpha catalytic subunit P62136 0,089 -8 0,12 
Myosin light polypeptide 6 P60660 0,092 -4 0,29 
Microtubule-associated protein 
RP/EB family member 2 Q15555 0,092 -6 0,12 
Rab GDP dissociation inhibitor beta 
(Rab GDI beta) P50395 0,093 -8 0,046 
Programmed cell death 6-interacting protein 
(PDCD6-interacting protein) Q8WUM4 0,095 3 0,45 
Alpha-soluble NSF attachment protein 
(SNAP-alpha) P54920 0,095 -5 0,017 
Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta 1 P62873 0,095 -4 0,22 
14-3-3 protein theat P27348 0,099 -4 0,38 
14-3-3 protein zeta/delta P63104 0,099 -4 0,38 
GRP75 Mortalin P38646 0,104 1 0,81 
Protein disulfide-isomerase A6 Q15084 0,112 -1 0,68 
Integrin α-IIb P08514 0,143 -8 0,55 
Nucl. assembly prot 1 P55209 0,177 -4 0,39 
Table 10a: Platelet proteins with low biological variance (pH 4-7) decreased with HP diet. 
Ratio and paired t-test values were calculated from the HP group at the two time points. CV 
is the coefficient of variance of the proteins. Ratios of the NP group are also all decreasing 
with time (data not shown). 
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pI range 6-9   
Protein Name SwissProt Acc.No. CV 
% change 
HP diet 
paired t-test 
HP diet 
Profilin-1 P07737 0,074 1 0,79 
Cyclophilin A P62937 0,082 -2 0,57 
Cyclophilin A P62937 0,092 -2 0,64 
Triosephospahate-Isomerase P60174 0,103 -2 0,68 
Mitogen-activated protein kinase 1 (ERK2) P28482 0,103 -6 0,16 
Voltage-dependent 
anion-selective channel protein 3 Q9Y277 0,112 -7 0,11 
Fructose-bisphosphate aldolase A P04075 0,115 -2 0,63 
Calponin-2 (Calponin H2; smooth muscle) 
(Neutral calponin) Q99439 0,115 -9 0,083 
Tyrosyl-tRNA synthetase; cytoplasmic P54577 0,12 -1 0,87 
Dual specificity protein phosphatase 3 P51452 0,121 -1 0,77 
Actin-related protein 2/3 complex subunit 2 O15144 0,125 -6 0,19 
Isocitrate Dehydrogenase P48735 0,128 -8 0,067 
Protein-L-isoaspartate(D-aspartate) 
O-methyltransferase P22061 0,128 4 0,36 
Glyceraldehyde-3-phosphate 
dehydrogenase P04406 0,129 -2 0,77 
Proteasome subunit alpha type 2 P25787 0,129 -2 0,72 
Proteasome subunit alpha type 4 P25789 0,137 -3 0,63 
Proteasome subunit alpha type 7 O14818 0,147 -5 0,54 
Glyceraldehyde-3-phosphate dehydrogenase P04406 0,155 -4 0,63 
Table 11b: Platelet proteins with low biological variance (pH 6-9) decreased with HP diet. 
Ratio and paired t-test values were calculated from the HP group at the two time points. CV 
is the coefficient of variance of the proteins. Ratios of the NP group are also all decreasing 
with time (data not shown). 
 
 
Further many different plasma proteins like albumin and haptoglobin were found to 
be highly significantly increased in the platelet proteome analysis in all after treatment 
measurements of the HP and NP study group (see table 15). Haptoglobin was 
increased by 69 % (p = 0.0113) after 3 weeks in the HP diet group and by 268 % (p = 
0.0059) after 3 weeks in the NP diet group. Albumin was increased by 233 % (p = 
0.0038) after 3 weeks in the HP group and by 323 % (p = 8.9 * 106) after 3 weeks in 
the NP group. Other plasma proteins that were significanty increased after 3 weeks 
intervention time in both groups were Fibrinogen, Apolipoproteins C-III precursor 
protein, cytoplsamatic antiproteinase, apolipoprotein A-I precursor protein or C4b-
binding protein alpha.  
Normally small amounts of plasma proteins like haptoglobin and albumin can be 
detected in platelets which are believed to take place in their open canalicular 
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system. This pore system soaks them up and thereby plasma proteins can appear in 
proteome analysis.  
There are two possible reasons for this event. The first reason is that there is a 
severe plasma contamination in all after treatment samples and therefore these 
highly abundant plasma proteins were increased in the platelet analysis. And the 
second reason is that albumin and haptoglobin (which has the highest increase after 
3 weeks treatment) are that highly increased in plasma, so that – since the open 
canalicular system soaks proteins up relatively to their concentration in plasma – the 
effect of this high increase is visible even in platelet analysis. Therefore haptoglobin 
and albumin in plasma were measured (see 4.7.3). Since no significant changes 
could be found in plasma after 3 weeks treatment in HP and NP group the significant 
increase of the huge amount of different plasma proteins in the platelet proteome are 
supposed to be a contamination during separation of plasma proteins from platelets 
by gel filtration. Probably the plasma contamination happened because of too short 
columns during gel filtration at the second timepoint after 3 weeks tratment. When a 
collumn is too short in size exclusion chromatography the eultion profile is too small 
and the fractions that are supposed to be separated are contaminated (see 4.2.1.2.). 
Thereby the platelet fraction was contaminated with plasma proteins.  
53 % of all significantly changed spots derived from plasma contamination. If the 
contamination would be smaller than 5 % there would be no interference to the 
normalisation of the DeCyder software. But since one of the normalisation steps of 
the DeCyder program normalises every spot on a gel by a median of all spot 
intensities of the gel, the results were distorted. Because the median of all spot 
intensities of the plasma contaminated samples differed a lot from the non-
contaminated samples. Therefore the normalization step of the DeCyder software 
even worsened the results.  
To get rid of the interference in the normalisation by the plasma contamination in the 
Decyder Programm normalisation had to be done manually in a different way. 
Therefore the median of every single gel of 4 proteins with low biological variance at 
the pH 4 – 7 and 5 proteins of pH 6 – 9 were calculated and every spot was 
normalized with the median of its gel. (see tables 11 and 12)  
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pI range 4-7 
  
Spot id Protein Name SwissProt  Acc. no. CV-all 
2041 14-3-3 protein gamma P61981 0.084 
2062 Peroxiredoxin-6 P30041 0.086 
2094 Growth factor receptor-bound protein 2 P62993 0.088 
1954 F-actin capping protein beta subunit (Cap Z beta) P47756 0.088 
Table 12: Platelet proteins with low biological variance were taken for normalization for pI 
range 4 – 7.  
 
 
pI range 6-9 
  
Spot id Protein Name SwissProt  Acc. no. CV-all 
1724 Profilin-1 P07737 0.074 
1671 Cyclophilin A P62937 0.082 
1672 Cyclophilin A P62937 0.092 
1488 Triosephospahate-Isomerase P60174 0.103 
1115 Mitogen-activated protein kinase 1 (ERK2) P28482 0.103 
Table 13: Platelet proteins with low biological variance were taken for normalization for pI 
range 6 – 9.  
 
 
Afterwards the spots had to be standardised (as usual standardised abundance in 
the DeCyder software) with the analogous spot in the internal standard on the same 
gel to further decrease technical variance of 2D electrophoresis. These corrections in 
the normalisation to overcome the interference of plasma contamination were done 
for both, the values of the first and the second time point. 
After these two normalisation steps the adjusted standardised abundances could be 
drawn on as basis for further calculations. Natural logarithm, common logarithm and 
2log were calculated and t-test and ratios for every spot in every possible combination 
of group and time point (see above) were assessed. 
After this approach to focuss the normalisation exclusivly on platelet proteins to 
exclude the interference of the plasma contamination now all the remaining platelet 
proteins with low biological variance (that were not chosen for normalisation) did not 
change significantly and had ratios very close to 1. (see table 13a and 13b) 
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pI range 4-7 
Spot ID Protein Name SwissProt Acc. No. 
% change 
HP diet 
paired t-test 
HP diet 
2041 14-3-3 protein gamma P61981 -1 0,221 
2062 Peroxiredoxin-6 P30041 3 0,324 
2094 Growth factor receptor-bound protein 2 P62993 1 0,647 
1954 F-actin capping protein beta subunit (Cap Z beta) P47756 1 0,324 
1810 Serine/threonine-protein phosphatase PP1-alpha catalytic subunit P62136 -3 0,515 
2192 Myosin light polypeptide 6 P60660 1 0,651 
1910 Microtubule-associated protein RP/EB family member 2 Q15555 -1 0,427 
1546 Rab GDP dissociation inhibitor beta (Rab GDI beta) P50395 -3 0,14 
772 Programmed cell death 6-interacting protein (PDCD6-interacting protein) Q8WUM4 9 0,094 
1918 Alpha-soluble NSF attachment protein (SNAP-alpha) P54920 0 0,898 
1884 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta 1 P62873 1 0,77 
2047 14-3-3 protein theat P27348 2 0,788 
2047 14-3-3 protein zeta/delta P63104 2 0,788 
1062 GRP75 Mortalin P38646 6 0,096 
1518 Protein disulfide-isomerase A6 Q15084 3 0,59 
568 Integrin α-IIb P08514 -2 0,602 
1367 Nucl. assembly prot 1 P55209 1 0,757 
Table 14a: Platelet proteins with low biological variance after correction. (pH 4-7) Ratio and 
paired t-test values were calculated from the HP group at the two time points. Median of 
proteins that are marked ´fat´ (bold) was used for normalization.  
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pI range 6-9 
Spot ID Protein Name SwissProt Acc. No. 
% change 
HP diet 
paired t-test 
HP diet 
1724 Profilin-1 P07737 0 0,886 
1671 Cyclophilin A P62937 1 0,713 
1672 Cyclophilin A P62937 1 0,577 
1488 Triosephospahate-Isomerase P60174 -1 0,683 
1115 Mitogen-activated protein kinase 1  (ERK2) P28482 -5 0,04 
1395 Voltage-dependent 
anion-selective channel protein 3 Q9Y277 -6 0,013 
1096 Fructose-bisphosphate aldolase A P04075 -1 0,714 
1248 Calponin-2 (Calponin H2; smooth muscle) (Neutral calponin) Q99439 -8 0,022 
700 Tyrosyl-tRNA synthetase; cytoplasmic P54577 0 0,88 
1581 Dual specificity protein phosphatase 3 P51452 -2 0,151 
1351 Actin-related protein 2/3 complex subunit 2 O15144 -5 0,022 
1013 Isocitrate Dehydrogenase P48735 -7 0,028 
1510 Protein-L-isoaspartate(D-aspartate) O-methyltransferase P22061 6 0,107 
1177 Glyceraldehyde-3-phosphate dehydrogenase P04406 0 0,839 
1530 Proteasome subunit alpha type 2 P25787 0 0,559 
1432 Proteasome subunit alpha type 4 P25789 -2 0,499 
1061 Proteasome subunit alpha type 7 O14818 -4 0,403 
1200 Glyceraldehyde-3-phosphate dehydrogenase P04406 -3 0,659 
Table 15b: Platelet proteins with low biological variance after correction. (pH 6-9) Ratio and 
paired t-test values were calculated from the HP group at the two time points. Median of 
proteins that are marked ´fat´ (bold) was used for normalization.  
 
 
After the two normalization steps ratios and paired and unpaired t-test of all possible 
combinations of the two groups at the two time points were calculated. A paired t-test 
could not always be accomplished, since in some of the combinations of the groups 
there were not the same individuals that were compared.  
 
7.1.4. Influence of HP diet on platelet 2D DIGE pH 4-7 analysis- corrected to 
get rid of plasma protein contamination 
After correcting the plasma contamination, the number of significantly changed 
protein spots increased dramatically when the baseline values and the after 3 weeks 
treatment values were compared. There was nearly no change in the number of 
significant protein spots when the two groups were compared at the baseline or after 
3 weeks respectively.  
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Table 16: Number of significant events, significant spots and artefacts for all possible 
combinations of groups and time points. Percentage of clearly defined protein spots from all 
significant events. Numbers (1-6) describe the calculation groups in statistical analysis (see 
figure 5 page 36) 
 
 
The percentages of significant proteins from all significant events across the 
calculation groups are between 77 % and 86% apart from two exceptions. When 
comparing the two after treatment groups, the percentage of significant protein is 57 
and when comparing the two groups at the baseline the percentage of significant 
proteins is 56%. At figure 8 the total significant events, the number of artefacts and 
the number of significant proteins are shown. 
In comparison to the number of significant protein spots, the proportion of significant 
protein spots and artefacts was similar before and after correction of the plasma 
contaminaton. 
 
 
  
1 
paired 
t-test 
1 
unpaired  
t-test 
2 
unpaired 
t-test 
3 
unpaired 
t-test 
4 
paired 
t-test 
4 
unpaired 
t-test 
5 
unpaired 
t-test 
6 
unpaired 
t-test 
significant events 392 297 42 285 389 295 41 381 
protein spots 320 254 24 219 317 246 23 311 
artefacts 72 43 18 66 72 49 18 70 
% protein 82% 86% 57% 77% 81% 83% 56% 82% 
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Figure 8: Number of HP and NP-related protein spot changes in pH range 4-7: All possible 
combinations of groups and time points were calculated to get an overview of possible 
interference of the standardized nutrition and grouped individuals. Numbers (1-6) describe 
the calculation groups in statistical analysis (see figure 5 page 36) 
 
 
Significantly changed spots were identified with mass spectrometry. On table 15 all 
identified significant proteins are listed. The percentage of change between the 
groups and t-test are named. 
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1 (3 weeks HP / baseline HP) 
spot  
number acessnr protein name % change 
t-test  
(unpaired) 
S980 Q86UX7 Unc-112-related protein 2 55 0,0005 
S1733 P00738 Haptoglobin? 69 0,0006 
S1453 P02679 Fibrinogen gamma 221 0,0006 
S1487 P02679 Fibrinogen gamma chain 35 0,0007 
S1013 P04003 C4b-binding protein alpha 247 0,0008 
S1486 P02679 Fibrinogen gamma chain A 29 0,0020 
S1714 P00738 Haptoglobin 207 0,0025 
S1098 P02679 Albumin 245 0,0031 
S1330 P02675 Fibrinogen beta chain [Precursor] 36 0,0032 
S2118 P02647 Apolipoprotein A-I precusor 354 0,0035 
S1750 P00738 Haptoglobin? 256 0,0040 
S1004 P04003 C4b-binding protein alpha ? 214 0,0046 
S1343 P02675 Fibrinogen beta chain 33 0,0060 
S1693 P00738 Haptoglobin 50 0,0071 
S1401 P02675 Fibrinogen beta chain 51 0,0071 
S682 P02787 Serotransferrin precursor ? 17 0,0091 
S966 Q05682 Caldesmon 21 0,0094 
S516 P01023 alpha-2-macroglobulin 246 0,0113 
S1499 P02679 Fibrinogen gamma chain 12 0,0122 
S1451 P02679 Fibrinogen gamma chain precursor 28 0,0142 
S1326 P02675 Fibrinogen beta chain 32 0,0147 
S1489 P02679 Fibrinogen gamma 24 0,0173 
S1389 P02675 Fibrinogen beta chain 26 0,0189 
S1433 Q14141 Septin-6 11 0,0190 
S2155 P19105 Myosin regulatory light chain 2;  
nonsarcomeric 25 0,0202 
S2221 P02656 Apolipoprotein C-III precursor 209 0,0216 
S991 Q05682 Caldesmon 24 0,0226 
S938 Q15942 Zyxin 29 0,0265 
S2152 P24844 Myosin regulatory light chain 2;  
smoothmuscle isoform 22 0,0274 
S1885 O43396 Thioredoxin-like protein 1 8 0,0284 
S2142 P32119 Peroxiredoxin 2 ? 89 0,0319 
S947 Q15942 Zyxin 39 0,0458 
S463 Q9Y4L1 150 kDa oxygen-regulated protein  [Precursor] ? 18 0,0477 
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2 (3 weeks HP / 3 weeks NP) 
spot  
number acessnr protein name % change  
t-test  
(unpaired) 
S2051 P60900 Proteasome subunit alpha type-6 15 0,0096 
S752 P12814 alpha-actinin 1 91 0,0183 
 
3 (3 weeks HP / baseline NP) 
spot  
number acessnr protein name % change 
t-test  
(unpaired) 
S980 Q86UX7 Unc-112-related protein 2 79 0,0000 
S1453 P02679 fibrinogen gamma 234 0,0002 
S1487 P02679 Fibrinogen gamma chain 41 0,0003 
S2118 P02647 Apolipoprotein A-I precusor 488 0,0004 
S1733 P00738 Haptoglobin? 70 0,0006 
S1013 P04003 C4b-binding protein alpha 46 0,0006 
S1486 P02679 Fibrinogen gamma chain A 30 0,0012 
S1098 P02679 Albumin 265 0,0013 
S1330 P02675 Fibrinogen beta chain [Precursor] 41 0,0014 
S1750 P00738 Haptoglobin? 284 0,0017 
S1343 P02675 Fibrinogen beta chain 39 0,0019 
S1004 P04003 C4b-binding protein alpha ? 213 0,0029 
S1489 P02679 Fibrinogen gamma 26 0,0067 
S1401 P02675 Fibrinogen beta chain 48 0,0076 
S1326 P02675 Fibrinogen beta chain 36 0,0088 
S516 P01023 alpha-2-macroglobulin 263 0,0088 
S1501 P10644 cAMP-depandent protein kinase  type I-alpha regulatory subunit 12 0,0097 
S1714 P00738 Haptoglobin 81 0,0101 
S2161 P00738 Haptoglobin 16 0,0138 
S2142 P32119 Peroxiredoxin 2 73 0,0264 
S1499 P02679 Fibrinogen gamma chain 11 0,0280 
S1791 P04899 Guanine nucleotide-bindingproteinG(i),  
alpha-2 subunit -10 0,0291 
S1451 P02679 Fibrinogen gamma chain precursor 24 0,0308 
S1299 P10809 60kDa heat shock protein, mitochondrial 11 0,0309 
S1693 P00738 Haptoglobin 37 0,0335 
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4 (3 weeks NP / baseline NP) 
spot  
number acessnr protein name % change 
t-test  
(unpaired) 
S1013 P04003 C4b-binding protein alpha 336 0,0000 
S2118 P02647 Apolipoprotein A-I precusor 647 0,0000 
S1750 P00738 Haptoglobin? 386 0,0000 
S1004 P04003 C4b-binding protein alpha ? 275 0,0000 
S1453 P02679 fibrinogen gamma 236 0,0000 
S1098 P02679 Albumin 331 0,0000 
S1714 P00738 Haptoglobin 268 0,0000 
S1733 P00738 Haptoglobin? 204 0,0001 
S980 Q86UX7 Unc-112-related protein 2 81 0,0001 
S1343 P02675 Fibrinogen beta chain 49 0,0001 
S516 P01023 alpha-2-macroglobulin 343 0,0003 
S1330 P02675 Fibrinogen beta chain [Precursor] 43 0,0004 
S1489 P02679 Fibrinogen gamma 35 0,0006 
S1486 P02679 Fibrinogen gamma chain A 33 0,0007 
S1693 P00738 Haptoglobin 90 0,0011 
S1487 P02679 Fibrinogen gamma chain 34 0,0017 
S1326 P02675 Fibrinogen beta chain 38 0,0029 
S1451 P02679 Fibrinogen gamma chain precursor 39 0,0055 
S1142 Q9BR76 Coronin-1B 52 0,0060 
S1401 P02675 Fibrinogen beta chain 42 0,0161 
S2161 P00738 Haptoglobin 377 0,0178 
S2221 P02656 Apolipoprotein C-III precursor 223 0,0242 
S1299 P10809 60kDa heat shock protein, mitochondrial 10 0,0323 
S991 Q05682 Caldesmon 40 0,0387 
S463 Q9Y4L1 150 kDa oxygen-regulated protein  [Precursor] ? 17 0,0463 
 
 
   
5 (baseline HP / baseline NP) 
spot  
number acessnr protein name % change 
t-test  
(unpaired) 
S2216 O75947 ATP synthase subunit d, mitochondrial ? -13 0,0265 
 
6 (3 weeks NP / baseline HP) 
spot  
number acessnr protein name % change 
t-test  
(unpaired) 
S1013 P04003 C4b-binding protein alpha 338 0,0000 
S1714 P00738 Haptoglobin 307 0,0000 
S1750 P00738 Haptoglobin? 347 0,0000 
S2118 P02647 Apolipoprotein A-I precusor 470 0,0000 
S1098 P02679 Albumin 306 0,0000 
S1004 P04003 C4b-binding protein alpha ? 276 0,0000 
S1453 P02679 fibrinogen gamma 223 0,0001 
S1733 P00738 Haptoglobin? 203 0,0001 
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S1693 P00738 Haptoglobin 207 0,0003 
S1343 P02675 Fibrinogen beta chain 43 0,0005 
S516 P01023 alpha-2-macroglobulin 321 0,0008 
S2221 P02656 Apolipoprotein C-III precursor 379 0,0009 
S1330 P02675 Fibrinogen beta chain [Precursor] 37 0,0010 
S1486 P02679 Fibrinogen gamma chain A 31 0,0011 
S1142 Q9BR76 Coronin-1B 55 0,0014 
S980 Q86UX7 Unc-112-related protein 2 56 0,0018 
S1489 P02679 Fibrinogen gamma 33 0,0024 
S1451 P02679 Fibrinogen gamma chain precursor 43 0,0027 
S1389 P02675 Fibrinogen beta chain 38 0,0028 
S1487 P02679 Fibrinogen gamma chain 29 0,0045 
S1326 P02675 Fibrinogen beta chain 34 0,0049 
S1942 P02649 Apolipoprotein E3 precursor 93 0,0064 
S463 Q9Y4L1 150 kDa oxygen-regulated protein [Precursor] ? 22 0,0080 
S966 Q05682 Caldesmon ? 60 0,0105 
S772 Q8WUM4 
Programmed cell death 6-interacting 
protein  
(PDCD6-interacting protein) ? 
13 0,0132 
S1401 P02675 Fibrinogen beta chain 45 0,0152 
S1078 P43304 Glycerol-3-Phosphat-DH 28 0,0164 
S991 Q05682 Caldesmon 47 0,0186 
S2152 P24844 Myosin regulatory light chain 2;  
smoothmuscle isoform 21 0,0195 
S2216 O75947 ATP synthase subunit d, mitochondrial ? 11 0,0259 
S1499 P02679 Fibrinogen gamma chain 11 0,0302 
S1083 P43304 Glycerol-3-phosphate dehydrogenase;  
mitochondrial [Precursor] 22 0,0318 
S1318 P31146 Coronin-1A(Coronin-like rotein p57) 16 0,0331 
S682 P02787 Serotransferrin precursor ? 11 0,0416 
S1312 P31146 Coronin-1A ? 14 0,0441 
S1671 P30740 leukocyte elastase inhibitor -9 0,0466 
 
 
   
  
probable plasma contamination 
  
 
  
  
  
probable interference of control diet 
  
Table 17: List of identified significant spots of pH 4 – 7 gels. Proteins that probably derive 
from plasma contamination are marked with grey. Proteins that probably derive from 
interference of control diet are marked with light blue. Ratios and unpaired t-test results are 
named. Numbers (1-6) describe the calculation groups in statistical analysis (see figure 5 
page 36) 
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As visible on table 15 after the normalization with low variabel platelet proteins the 
significant increase of the plasma proteins in the after treatment values of the HP and 
NP group persists. Some of the proteins – like Unc-112-related protein 2, Caldesmon 
or 60kDa heat shock protein, mitochondrial – that are significantly changed with HP 
diet are also significantly changed in the NP diet and therefore seems not to be 
related mainly to the HP diet.  
The following table show only significantly changed proteins that are supposed to be 
changed only because of the HP diet.  
 
2 (3 weeks HP / 3 weeks NP) 
spot  
number acessnr protein name 
% change  
 
t-test  
(unpaired) 
S2051 P60900 Proteasome subunit alpha type-6 15 0,0096 
S752 P12814 alpha-actinin 1 -9 0,0183 
     
1 (3 weeks HP / baseline HP) 
spot  
number acessnr protein name 
% change 
 
t-test  
(unpaired) 
S1433 Q14141 Septin-6 11 0,0190 
S2155 P19105 Myosin regulatory light chain 2; 
nonsarcomeric 25 0,0202 
S938 Q15942 Zyxin 29 0,0265 
S1885 O43396 Thioredoxin-like protein 1 18 0,0284 
S2142 P32119 Peroxiredoxin 2 ? -11 0,0319 
S947 Q15942 Zyxin 39 0,0458 
     
3 (3 weeks HP / baseline NP) 
spot  
number acessnr protein name 
% change 
 
t-test  
(unpaired) 
S1501 P10644 cAMP-dependent protein kinase  type I-alpha regulatory subunit 12 0,0097 
S2142 P32119 Peroxiredoxin 2 -37 0,0264 
S1791 P04899 Guanine nucleotide-bindingproteinG(i),  
alpha-2 subunit -10 0,0291 
Table 18: Identified significant spots of pH 4 – 7 gels associated with HP diet. Numbers (1-3) 
describe the calculation groups in statistical analysis (see figure 5 page 36) 
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7.1.5. Influence of HP diet on platelet proteome 2D DIGE pH 6-9 analysis- 
corrected to get rid of plasma protein contamination 
The number of singnificantly changed spots after correction of the plasma 
contamination differed a lot from before. But in contrast to pH 4 – 7 they didn’t 
increase. All except one decreased. The comparison of the HP diet at the two 
different timepoints increased after the correction of the plasma contamination.  
 
Table 19: Number of significant events, significant spots and artefacts for all possible 
combinations of groups and time points. Percentage of clearly defined protein spots from all 
significant events. Numbers (1-6) describe the calculation groups in statistical analysis (see 
figure 5 page 36) 
 
 
The number of significant spots differs a lot when calculated with paired or unpaired 
t-test in the HP and the NP diet group. In the HP group there are 212 events found 
when calculated with paired t-test, but only 80 when calculated with unpaired t-test. 
Though, all of the 80 significant events are also found in the paired t-test calculation. 
In the NP group there are 37 significant events that are different, depending on the t-
test that is performed. Further it is worth to mention that at comparison 1 (3 weeks 
HP / baseline HP) there are much less significant protein spots than in comparison 4 
(3 weeks NP / baseline NP) which is actually used only as control. The percentages 
of significant proteins from all significant events across the calculation groups are 
between 69 % and 86% apart from one exception. When comparing the two after 
treatment groups, the percentage of significant protein is 54%. At figure 9 the total 
significant events, the number of artefacts and the number of significant proteins are 
shown. 
In comparison to the number of significant protein spots, the proportion of significant 
protein spots and artefacts was similar before and after correction of the plasma 
contaminaton. 
 
  
1 
paired 
t-test 
1 
unpaired 
t-test 
2 
unpaired 
t-test 
3 
unpaired 
t-test 
4 
paired 
t-test 
4 
unpaired 
t-test 
5 
unpaired 
t-test 
6 
unpaired 
t-test 
significant events 212 80 56 200 198 161 35 96 
protein spots 158 66 30 171 147 138 24 71 
artefacts 54 14 26 29 51 23 11 25 
% protein 75% 83% 54% 86% 74% 86% 69% 74% 
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Figure 9: Number of HP and NP-related protein spot changes in pH range 6-9: All possible 
combinations of groups and time points were calculated to get an overview of possible 
interference of the standardized nutrition and grouped individuals. Numbers (1-6) describe 
the calculation groups in statistical analysis (see figure 5 page 36) 
 
 
Significant changed spots were identified with mass spectrometry. On table 18 all 
identified significant proteins are listed. The percentage of change between the 
groups and t-test are named. 
 
 
 
1 (3 weeks HP / baseline HP) 
spot  
number acessnr protein name % change 
t-test  
(unpaired) 
B1386 Q9Y277 Voltage dependent anion  
selective channel protein 3 -8 0,0055 
B645 P27338 Monoamine Oxidase B -31 0,0087 
B206 P19367 Hexokinase-1 -12 0,032 
B202 Q7KZF4 Staphylococcal nuclease  domain-containing protein -15 0,0111 
B760 P02675 Fibrinogen beta chain 22 0,0278 
B448 P43405 Tyrosine-protein kinase SYK -10 0,0284 
B726 P02675 Fibrinogen beta chain 14 0,0364 
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2 (3 weeks HP / 3 weeks NP) 
spot  
number acessnr protein name % change 
t-test  
(unpaired) 
B1460 P18669 Phosphoglycerate mutase 1 -8 0,0203 
 
3 (3 weeks HP / baseline NP) 
spot  
number acessnr protein name % change 
t-test  
(unpaired) 
B871 Q13418 Integrin linked kinase -66 0,0000 
B518 P02671 Fibrinogen alpha chain 41 0,0050 
B726 P02675 Fibrinogen beta chain 21 0,0050 
B528 P02671 Fibrinogen alpha chain 46 0,0051 
B760 P02675 Fibrinogen beta chain 33 0,0056 
B541 P02671 Fibrinogen alpha-chain 52 0,0089 
B759 P02675 Fibrinogen beta chain 29 0,0098 
B539 AAA52426 Fibrinogen alpha chain 33 0,0114 
B527 P02671 Fibrinogen alpha chain 30 0,0115 
B1460 P18669 Phosphoglycerate mutase 1 -8 0,0146 
B154 P53396 ATP-citrate synthase -30 0,0154 
B1431 P00915 Carbonic Anhydrase 1 -203 0,0172 
B202 Q7KZF4 Staphylococcal nuclease domain-containing protein -16 0,0176 
B206 P19367 Hexokinase-1 -13 0,0187 
B863 Q13418 Integrin linked protein kinase 1 -6 0,0238 
B614 P02675 Fibrinogen beta chain ? 22 0,0272 
B1714 P68871 Haemoglobin subunit beta -289 0,0274 
B1395 Q9Y277 
Voltage-dependent 
anion-selective channel protein 
3 
-8 0,0275 
B1128 Q15942 Zyxin ? -12 0,0482 
 
4 (3 weeks NP / baseline NP) 
spot  
number acessnr protein name % change 
t-test  
(unpaired) 
B750 P02671 Fibrinogen alpha chain 61 0,0095 
B538 P02671 Fibrinogen alpha chain 43 0,0097 
B1408 P02671 Fibrinogen alpha-chain 28 0,0128 
B517 P02675 Fibrinogen beta chain 31 0,0295 
B264 Q13418 Integrin linked kinase -34 0,0475 
 
 5 (baseline HP / baseline NP) 
spot  
number acessnr protein name % change 
t-test  
(unpaired) 
B871 Q13418 Integrin linked kinase -35 0,0174 
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6 (3 weeks NP / baseline HP) 
spot  
number acessnr protein name % change 
t-test  
(unpaired) 
B1510 P22061 Protein-L-isoaspartate(D-aspartate) O-methyltransferase 13 0,0236 
 
  
probable plasma contamination 
  
 
  
probable interference of control diet 
  
Table 20: List of identified significant spots of pH 6 – 9 gels. Proteins that probably derive 
from plasma contamination are marked with grey. Proteins that probably derive from 
interference of control diet are marked with light blue. Ratios and unpaired t-test results are 
named. Numbers (1-6) describe the calculation groups in statistical analysis (see figure 5 
page 36) 
 
 
On table 18 after the normalization with the low variable platelet protein of the spot 
volumes there are still some significantly increased standardized abundances of 
spots in all after treatment values left that probably derive from plasma 
contamination. All of these spots are fibrinogen. Some of the proteins that are 
significantly changed with HP diet are also significantly changed with NP diet, when 
there was no obvious difference in food composition. These proteins were excluded 
of the results.  
Table 19 show significantly changed platelet proteins that are supposed to be only 
influenced by the HP diet.  
 
 
1 (3 weeks HP / baseline HP) 
spot  
number acessnr protein name % change 
t-test  
(unpaired) 
B1386 Q9Y277 Voltage-dependent anion- 
selective channel protein 3 -8 0,0055 
B645 P27338 Amine Oxidase -31 0,0087 
B206 P19367 Hexokinase-1 -12 0,032 
B202 Q7KZF4 Staphylococcal nuclease  domain-containing protein -15 0,0111 
B448 P43405 Tyrosine-protein kinase SYK -10 0,0284 
 
2 (3 weeks HP / 3 weeks NP) 
spot  
number acessnr protein name % change 
t-test  
(unpaired) 
B1460 P18669 Phosphoglycerate mutase 1 -8 0,0203 
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3 (3 weeks HP / baseline NP) 
spot  
number acessnr protein name % change 
t-test  
(unpaired) 
B1460 P18669 Phosphoglycerate mutase 1 -8 0,0146 
B154 P53396 ATP-citrate synthase -30 0,0154 
B1431 P00915 Carbonic Anhydrase 1 -203 0,0172 
B202 Q7KZF4 Staphylococcal nuclease domain-containing protein -16 0,0176 
B206 P19367 Hexokinase-1 -13 0,0187 
B1714 P68871 Haemoglobin subunit beta -289 0,0274 
B1395 Q9Y277 Voltage-dependent anion- 
selective channel protein 3 -8 0,0275 
B1128 Q15942 Zyxin ? -12 0,0482 
Table 21: Identified significant spots of pH 6 – 9 gels associated with HP diet. Numbers (1-3) 
describe the calculation groups in statistical analysis (see figure 5 page 36) 
 
 
After the normalization by the low variable platelet proteins in the pH range 6 - 9 to 
eliminate the influence of plasma contamination on the first normalization step, the 
results from pH 6 – 9 did not considerably change or some of the significantly 
changed proteins lost or worsened their significance. Monoamine oxidase B for 
example differed in the ratio by 2 % and significance decreased by 0.0033. Further 
proteins, like voltage-dependent anion-selective channel protein 3 that are supposed 
to be proteins with low biological variation suddenly were significantly changed with 
HP diet.  
Since most plasma proteins occur in 2D separation of pH range 4 – 7 and hardly 
none of the plasma proteins has a pI larger than 7, the primary analysis of the results 
of the gels from pH 6 – 9 seemed to be the proper one: 
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1 (3 weeks HP / baseline HP) 
spot  
number acessnr protein name % change 
t-test  
(unpaired) 
645 P27338 Amine Oxidase -33 0,0054 
206 P19367 Hexokinase-1 -12 0,037 
1431 P00915 Carbonic Anhydrase 1 -29 0,042 
 
3 (3 weeks HP / baseline NP) 
spot  
number acessnr protein name % change 
t-test  
(unpaired) 
154 P53396 ATP-citrate synthase -31 0,0051 
206 P19367 Hexokinase-1 -16 0,0094 
1431 P00915 Carbonic Anhydrase 1 -214 0,014 
1013 P48735 Isocitrate Dehydrogenase -12 0,017 
1460 P18669 Phosphoglycerate mutase 1 -11 0,018 
1714 P68871 Haemoglobin subunit beta -313 0,019 
448 P43405 Tyrosine-protein kinase SYK -14 0,021 
6 P51659 Peroxisomal multifunctional? 10 0,023 
1227 Q15942 Zyxin ? -10 0,031 
201 P19367 Hexokinase-1 -29 0,034 
515 P43304 Glycerol-3-phosphate dehydrogenase;mitochondrial precursor -19 0,04 
Table 22: Identified significant spots of pH 6 – 9 gels associated with HP diet. Numbers (1,3) 
describe the calculation group in statistical analysis (see figure 5 page 36) 
 
 
7.1.6. HP related decrease of Monoamine Oxidase B expression in platelets 
Mao-B expression in platelets significantly decreased by 33% with HP diet (P < 
0.0054) (paired t-test). Mao-B has with this p value the highest significance from all 
HP diet related proteins. A slight decrease of Mao-B expression was also observed in 
the NP group but becomes not significant. However therefore no significant decrease 
of Mao-B expression could be found by comparing the after treatment values of the 
NP and HP group (see figure 10). 
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Figure 10: Platelet Mao-B expression of the study individuals in the NP (n =12) and HP group 
(n = 12) at the baseline and after 3 weeks treatment measured by 2D DIGE. Results are 
presented as means ± standard deviations. Significances are calculated with paired student 
t-test **P < 0.0054 
 
 
Figure 10 shows the mean standardised abundance of Mao-B expression across the 
study groups and Figure 11 and 12 show Mao-B expression in each individual of the 
NP and the HP group and thereby illustrate that the protein expression changes of 
Mao-B are very uniform in the HP group in comparison to the NP group. 
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Figure 11: Standardized abundance of Mao-B expression from each individual of the NP 
group.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Standardized abundance of Mao-B of each individual of the HP group 
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7.1.7. Platelet Monoamine oxidase B expression and reaction time 
correlates significantly 
To evaluate the influence of a high protein diet on cognitive functions of the study 
individuals a Go/NoGo test was performed. 
The HP group had a significantly decreased mean reaction time (-25.5 +/- 11.6 msec)  
and a decrease in the number of errors in the Go/No-Go test. (Jakobsen 2010)  
The main function of Mao-B is to degrade dopamine in the central nervous system 
which is an important neurotransmitter in the process of learning. Since platelets are 
also described to act as surrogate cells for neurons platelet Mao-B expression was 
correlated with their reaction time from the respective study individuals. 
As shown on figure 13, there is a significant correlation (r = 0.477; p = 0.0213) 
between the reaction time and the Mao-B expression in platelets.  
 
 
Figure 13: Correlation between reaction time measured with Go/NoGo test and Mao-B 
expression in platelets. Correlation was calculated with Pearson Test. d are the differences 
from baseline to the after treatment measurement. r is the correlation. p is the significance of 
the correlation 
 
 
7.1.8. HP related increase of Myosin regulatory light chain 2 – MLC-2 
expression in platelets 
One study hypothesis was that the HP diet should increase muscle strength. In a 
previous proteomics study elderly subjects are characterised by a reduced 
phosphorylation of myosin regulatory chain isoform in the vastus lateralis muscle, 
which could contribute to the impairment of muscle performance (Gelfi, 2005). In our 
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study platelets should be a surrogate cell for muscle cells and therefore we were 
espcially interested in Myosin regulatory light chain. 
Five isoforms of MLC-2 were identified on the 2D DIGE gels (pH 4-7) in this study. 
Two smooth muscle isoforms and three nonsarcomeric isoforms. Two of these 5 
isoforms are significantly changed with HP diet in the platelet proteome, namely a 
MLC-2 nonsarcomeric isoform (spotnr. 2155) and a smooth muscle isoform (spotnr. 
2152). (see figure 14) 
The HP diet induced a significant increase of P19105 Myosin regulatory light chain 2;  
nonsarcomeric (25%; P < 0.0202; Spot number Spot number 2155) with the pI 4.61 
but no change of the isoform with the pI 4.67 with the same MS identification 
P19105. In parallel the P24844 Myosin regulatory light chain 2; smooth muscle 
isoform (22% P < 0.0274 2152) with the pI 4.72 increased in the HP group but 
change of the isoform with the pI 4.86 was observed. However P24844 with the pI 
4.72 is also significantly decreased in the NP group and therefore cannot be clearly 
related to the HP-diet. 
 
 
 
Figure 14: Partial view of 2D DIGE gel pH 4 – 7 showing the 5 isoforms of MLC-2. Percent 
changes and significances (unpaired student t-test) associated with HP diet are shown. 
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Figure 15: MLC-2 smooth muscle isoform expression of the study individuals in the NP (n = 
12) and HP group (n = 12) at the baseline and after 3 weeks treatment measured by 2D 
DIGE. Results are presented as means ± standard deviations. Significances are calculated 
with paired student t-test **P < 0.0195; *P < 0.0274 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: MLC-2 nonsarcomeric isoform expression of the study individuals in the NP (n = 
12) and HP group (n = 12) at the baseline and after 3 weeks treatment measured by 2D 
DIGE. Results are presented as means ± standard deviations. Significances are calculated 
with paired student t-test **P < 0.0202 
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7.1.9. Myosin regulatory light chain 2 and muscle strength 
A muscle strength test (HGE = Handgrip Endurance HGS = Handgrip Strength) was 
performed with the study individuals. There could be no significant changes 
monitored in muscle strength between the HP and the NP group after 3 weeks 
treatment. But HGE and HGS increased in both groups between baseline and after 3 
weeks. This may be due to a training effect.  
Since platelets were used as a surrogate cells for muscle cells, and myosin 
regulatory light chain 2 is an important factor for muscle contraction, the muscle 
strength results were correlated with the expression levels of all the myosin 
regulatory light chain 2 isoforms. With two of the isoforms (spotnr. 2154 and 2157) a 
significant correlation was found. (see figures 17 and 18) However, these two 
correlating spots were not significantly changed with HP diet. 
 
 
 
 
Figure 17: Correlation between MLC-2 isoform 2154 (=spotnr.) and endurance. Endurance: 
measured as handgrip enduance at 70 % of own max strength (sec). d: differences from first 
to final measurement. Correlation was calculated with Pearson Test. r is the correlation. p is 
the significance of the correlation 
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Figure 18: Correlation between MLC-2 isoform 2157 (=spotnr.) and endurance. Endurance: 
measured as handgrip enduance at 70 % of own max strength (sec). d: differences from first 
to final measurement. Correlation was calculated with Pearson Test. r is the correlation. p is 
the significance of the correlation 
 
 
The isoforms that correlated with the muscle strength test were not significantly 
changed in the HP and NP diet group. There was no significant correlation between 
the muscle strength and MLC-2 nonsarcomeric isoform (spotnr. 2155) that was 
significantly changed with HP diet. 
 
7.2. Influence of High Protein diet on plasma proteome 
EDTA plasma was separated from blood cells by centrifugation and individuals were 
pooled to groups with 4 or 3 persons per group (see chapter 4.2.1.1 and 4.2.1.3). 
High abundant plasma proteins were filtered out by affinity chromatography. Plasma 
proteome was investigated with 2D DIGE gels in the pH range 4 – 7, since most of 
the plasma proteins have an acidic pI. 
The total number of spots on the master gel is 2157. The average number of 
detected spots on the other gels is 2096 ± 151. The average number of matched 
spots to the master is 1221 ± 300.  
Expression changes between the groups were estimated and their significance was 
calculated with student t-test. A HP diet effect was screened with 3 different 
calculations: The HP group was compared at the first time point and after 3 weeks 
intervention time (1), the HP and the NP groups were compared at the second time 
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point and the HP group at the second time point (2) and the NP group at the first time 
point (3) were compared.  
Additionally the NP group was compared at the baseline and after 3 weeks 
intervention time (4), the HP and the NP groups were at the baseline (5) and the NP 
group at the after treatment time point and the HP group at the baseline (6) were 
compared.  
However the change in the diet of the NP group may have an influence on plasma 
protein composition. 
Moreover also a substantial number of false positives may accumulate at the 0.01 
confidence level because 1% of sample differences will be significant by change 
even if no changes in protein expression exist between the two samples 
Therefore proteins that happened to be significant in the t-tests of 4-6 are supposed 
to be not HP related protein expression changes. 
 
 
 
Figure 19: Diagram of calculations for statistical analysis to find HP diet associated changes 
(1-3) or false positive changes (4-5). 
 
 
If the same individuals were compared within the same treatment group, paired 
student t-test was made. Unpaired t-test had to be calculated for comparison across 
the treatment groups (of the HP and NP group). Additionally an unpaired t-test was 
calculated within a treatment group to have an adequate comparison of the 
significant changes also between the two different treatment groups. The significant 
range was defined p < 0.05 and the number of significant events was counted. Not all 
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artefacts, too low abundant or badly separated protein. These events were also 
counted. To have also an overview of another reason for false positive events the 
percentage of well defined protein spots of all significant events was calculated (see 
table 21). 
Significantly changed spots, that were associated with HP and NP diet, were 
analysed with mass spectrometry. 
 
 
  
1 
paired 
t-test 
1 
unpaired 
t-test 
2 
unpaired 
t-test 
3 
unpaired 
t-test 
4 
paired 
t-test 
4 
unpaired 
t-test 
5 
unpaired 
t-test 
6 
unpaired 
t-test 
significant events 34 34 26 36 29 29 23 27 
protein spots 25 25 20 26 16 16 17 19 
artefacts 9 9 6 10 13 13 6 8 
% protein 74% 74% 77% 72% 55% 55% 74% 70% 
Table 23: Number of significant events, significant spots and artefacts for all possible 
combinations of groups and time points. Percentage of significant protein spots of all 
significant events. The numbers (1-6) describe the calculation groups in statistical analysis 
(see figure 19) 
 
 
The number of significant protein spots with HP diet is similar and higher than with 
NP diet. The number of significant events is exactly the same when calculated with 
paired or unpaired t-test in the NP and the HP groups. The percentage of significant 
protein spots of all significant events is in a range between 55 % and 74%. 
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Figure 20: Number of HP and NP-related protein spot changes in pH range 4-7: All possible 
combinations of groups and time points were calculated to get an overview of possible 
interference of the standardized nutrition and grouped individuals. The numbers (1-6) 
describe the calculation groups in statistical analysis (see figure 19) 
 
 
Significantly changed protein spots were identified with mass spectrometry. On table 
22 all identified significant proteins are listed. The percentage of change between the 
groups and t-test are named. 
 
 
 
 
 
1 (3 weeks HP / baseline HP) 
spot number acessnr protein name ratio t-test  (unpaired) 
886 P04217 Alpha 1 beta Glycoprotein -1,23 0,0088 
691 P09871 Complement C1; 
s subcomponent 1,12 0,039 
694 P09871 Complement C1; 
s subcomponent 1,11 0,041 
892 P04217 Alpha 1 beta glycoprotein -1,13 0,042 
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2 (3 weeks HP / 3 weeks NP) 
spot number acessnr protein name ratio t-test  (unpaired) 
1068 Q96KN2 Beta-ala-his-dipeptidase ? 1,43 0,012 
1001 P01042 Kininogen ? 1,42 0,017 
1328 P0C0L5 Complement C4 -1,26 0,032 
1319 P0C0L5 Coplement C4 -1,27 0,037 
931 P01031 Complement C5 1,13 0,04 
1626 P10909 Clusterin precursor 1,2 0,043 
  
3 (3 weeks HP / baseline NP) 
spot number acessnr protein name ratio t-test  (unpaired) 
1322 P0C0L5 Complement C4 -1,59 0,0048 
724 P01024 Complement C3 -1,3 0,0075 
696 P01024 Complement C3? -1,25 0,011 
1068 Q96KN2 Beta-ala-his-dipeptidase ? 1,37 0,013 
1626 P10909 Clusterin precursor 1,25 0,021 
460 Q14624 Inter-alpha-trypsin inhibitor heavy chain H4 precursor ? -1,48 0,023 
1965 P02753 Retinol binding protein -1,22 0,024 
1176 P01019 Angiotensinogen -1,17 0,033 
1299 P0C0L5 Complement C4 -1,26 0,034 
1498 P01024 Complement C3 2,06 0,037 
1001 P01042 Kininogen ? 1,35 0,038 
1319 P0C0L5 Coplement C4 -1,48 0,04 
717 P01024 Complement C3? -1,23 0,041 
562 P01024 Complement C3? -1,32 0,042 
1330 P0C0L5 Complement C4 -1,29 0,048 
1486 P0C0L5 Complement C4 -1,27 0,049 
  
4 (3 weeks NP / baseline NP) 
spot number acessnr protein name ratio t-test  (unpaired) 
1194 P01008 Antithrombin -1,06 0,023 
1470 P01024 Complement C3 1,8 0,027 
  
5 (baseline HP / baseline NP) 
spot number acessnr protein name ratio t-test  (unpaired) 
1965 P02753 Retinol binding protein -1,32 0,0069 
1176 P01019 Angiotensinogen -1,16 0,011 
1322 P0C0L5 Complement C4 -1,57 0,045 
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6 (3 weeks NP / baseline HP) 
spot number acessnr protein name ratio t-test  (unpaired) 
645 P00751 Complement CB 1,15 0,011 
1470 P01024 Complement C3 2,21 0,011 
96 P01024 Complement C3 1,4 0,047 
     
       probable interference of control diet 
Table 24: List of identified significant spots of pH 4 – 7 gels. Ratios and unpaired t-test 
results are named. The numbers (1-6) describe the calculation groups in statistical analysis 
(see figure 19) 
 
 
7.3. Concentration of plasma amino acids after HP diet 
The effect of HP and NP diet on 19 different amino acids concetrations in plasma 
was also examined in this study from all study individuals at baseline and after 3 
weeks treatment period. Mean ratios and deviation of the individuals in one group 
were calculated and significance was estimated with paired t-test.  
In the plasma amino acid analysis several significant changes could be monitored in 
the HP diet as well as in the NP diet. Though the significant changes are not similar 
in the two experimental groups, the direction of the amino acid changes is almost 
always the same in both experimental groups. 
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NP HP 
amino acid mean 
% change deviation paired t-test 
mean 
% change deviation paired t-test 
ASP 64 0,42 0,0010 42 0,66 0,2956 
GLU 47 0,40 0,0055 21 0,30 0,0863 
ASN -2 0,07 0,2957 -4 0,18 0,5064 
SER 6 0,09 0,0592 4 0,17 0,3851 
GLN 0 0,05 0,9314 -8 0,08 0,0184 
HIS -9 0,11 0,0216 -9 0,14 0,0500 
GLY -8 0,22 0,2817 -23 0,09 0,0001 
THR -4 0,20 0,2740 -12 0,22 0,0762 
ALA -1 0,16 0,7131 -3 0,24 0,7035 
ARG 1 0,11 0,9287 -8 0,22 0,1087 
TAU 8 0,12 0,0698 -2 0,07 0,2891 
TYR 3 0,10 0,4801 11 0,23 0,1532 
A-A-BUT -3 0,19 0,2378 -32 0,28 0,0213 
VAL 1 0,14 0,9713 33 0,15 0,0000 
MET 22 0,15 0,0005 15 0,27 0,1475 
TRY 18 0,17 0,0046 20 0,14 0,0026 
ILE 6 0,12 0,1555 16 0,22 0,0426 
PHE 5 0,10 0,1168 17 0,18 0,0125 
LEU 3 0,11 0,4365 10 0,21 0,2126 
Total AA 0 0,09 0,8225 0 0,12 0,9850 
Table 25: Mean ratios and deviation of the individuals in the NP and HP study groups and 
paired t-test comparing the individual concentrations at the two time points. The red marked 
amino acids are the ones that are significantly changed after 3 weeks in the HP group and 
the blue marked are significant changes in the NP group. Amino acids marked in green are 
significantly changed in both groups. 
 
 
There was no change in total amino acis concentration between the groups.  
Valine, methionine, tryptophan and phenylalanine belong to the group of essential 
amino acids. Valine significantly increased by 33 % in the HP diet group whereas 
Methionine is increased by 22 % in the NP diet group. Tryptophan increased 
significantly in both groups by about 20 %. Phenylalanine increased only in the HP 
diet group by 17 % after three weeks of changed nutrition.  
Aspartate, glutamine, glutamate and glycine belong to the group of non-essential 
amino acids.  
Aspartate significantly increased by 64 % in the NP diet group at the end of the 
study. Glutamine decreased by 47 % in the HP diet group. Glutamate significantly 
increased by 7 % in the NP diet group. Glycine decreased in the HP diet group by 23 
% after three weeks of changed nutrition. 
The significance of changes in amino acid concentration between the groups and 
time points was also calculated with unpaired t-test. Six different combinations of 
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groups and time points are possible: the comparison between the two time points of 
one group, the comparison between of the two groups at one time point and the 
comparison of the two different groups at two different time points. (see figure 19) On 
figure 21 the number of significant changed amino acids is charted. In the 
comparison of the amino acid concentrations at the two time points of the NP group, 
5 amino acids showed significant changes in concentration levels. In the comparison 
of the amino acid concentrations at the two time points of the HP group 3 amino 
acids altered significantly. The evaluation of the two groups at the first time point 
showed no significant changes in amino acid concentrations. The concentration of 3 
amino acids changed significantly between the two groups at the second time point. 
4 significant amino acid concentration changes result from the comparison of the NP 
group at the first time point and the HP group at the second time point. Between the 
HP group at the first time point and the NP group at the second time point, significant 
concentration changes in 2 amino acids happened.  
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Figure 21: Number of HP and NP-related amino acid changes. All possible combinations of 
groups and time points were calculated to get an overview of possible interference of 
standardised nutrition and grouped individuals. The numbers (1-6) describe the calculation 
groups in statistical analysis (see figure 19) 
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7.4. Plasma parameter analysis 
7.4.1. Cholesterols and triglycerides 
Overall, fasting plasma total cholesterol at week 12 decreased by 7 % (p < 0.002) in 
the NP group. Fasting serum LDL cholesterol was by 9 % (p < 0.009) lower in the NP 
group after 3 weeks of the diet. Fasting plasma HDL cholesterol is significantly 
decreased by 7 % (p < 0.012) in the NP group and by 17 % (p < 0.002) in the HP 
group. The LDL/HDL cholesterol quotient is significantly decreased by 0.2 % (p < 
0.008). In fasting serum triacylglycerol no significant changes could be found. 
 
7.4.2. Homocysteine – Folate – Vitamin B12 
In this study a significant increase of vitamin B12 by 17 % (p < 0.014) and significant 
decrease of homocysteine by 18 % (p < 0.013) in the HP diet group were measured. 
A very strong and remarkable change is observed in the plasma folate concentration 
with a significant decrease by 48 % (p < 0.002) in the HP group and by 18 % (p < 
0.004) in the NP group.  
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Figure 22: Homocysteine cycle. In presence of vitamin B12 and folate, homocysteine is 
metabolized to methionine. Thus, the concentration of homocysteine is inversely proportional 
to the concentration of vitamin B12. S-Adenosylmethionine provides the methyl group for 
DNA methylation. % change with HP diet of homocysteine and Vitamin B12 are shown. 
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Figure 23: Vitamin B12 concentration in plasma of the NP and HP group at baseline and after 
treatment.  Results are presented as means ± standard deviations. Significances are 
calculated with paired student t-test. 
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Figure 24: Folate concentration in plasma of the NP and HP group at baseline and after 
treatment.  Results are presented as means ± standard deviations. Significances are 
calculated with paired student t-test. 
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Figure 25: Homocysteine concentration in plasma of the NP and HP group at baseline and 
after treatment.  Results are presented as means ± standard deviations. Significances are 
calculated with paired student t-test. 
 
 
7.4.3. Platelet Monoamine oxidase B expression and plasma vitamin B12 
concentration are inversely correlating 
Mao-B activity in platelets is described to be inversely related to vitamin B12 
concentration in plasma. (Regland 1991) Additionally it is described that MAO-B gene 
expression is selectively induced by reduced DNA methylation at specific CpC sites 
at the promoter. (Wong 2003) 
In this study a negative correlation between MaoB expression in platelets and vitamin 
B12 concentration in plasma (r = -0.46, p < 0.028) was assessed.  
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Figure 26: Correlation between maoB expression levels in platelets and vitamin B12 
concentration in plasma. Delta: differences from first to second time point. 
 
 
Since Mao-B expression is regulated by DNA methylation, vitamin B12 is part of the 
homocysteine cycle that leads to methylation and the correlation between Mao-B and 
vitamin B12 in this study, a connection between vitamin B12 and MAO-B promoter 
methylation can be suggested. 
 
7.4.4. Albumin and Haptoglobin 
The main function of haptoglobin is the transport of haemoglobin and it is an 
important marker for haemolysis and inflammation. Albumin is the most abundant 
plasma protein and belongs to the family of globular proteins. Its main function is to 
provide the maintenance of the colloid osmotic pressure.  
These two parameters were measured to confirm the suspicion of having a plasma 
contamination in the platelet proteome samples (see chapter 4.1.3.). These two 
parameters could not be read out of the 2D DIGE plasma proteome analysis because 
during sample preparation all high abundant proteins were filtered out.  
In plasma no significant changes were found in albumin and haptoglobin and 
therefore the suspicion of a plasma contamination was substantiated.  
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8. Discussion  
In this study several significant changes in platelet proteome, plasma proteome and 
in plasma parameters like vitamin B12 or folate were characterised with an animal HP 
diet. In the following chapters the various results are put in context with each other 
and are compared to similar studies. This might give an insight on the consequences 
of an animal HP diet. 
 
8.1. Influence of High Protein diet on platelet proteome 
After analysing the influence of a HP diet in the platelet proteome with 2D DIGE gels 
in pH range 4 – 7 and 6 – 9, 25 significantly changed proteins could be identified. 
The strongest expression changes were detected with monoamine oxidase B and 
myosin regulatory light chain 2 nonsarcomeric isoform and zyxin.  
Significant changes in the platelet proteome were not only visible with HP diet, but 
also with NP diet. This might be due to the plasma contamination of the gel-filtered 
platelets that occur in HP as well as NP after treatment values. An additional 
explanation other changes in HP and NP-related protein expression changes could 
be the rather short run-in phase of the study. The individuals could not adapt that fast 
– within a week – to the new way of nutrition and therefore the baseline values are 
still in an adaption phase.  
 
8.1.1. HP related decrease of Monoamine Oxidase B expression in platelets 
Monoamine Oxidase B (Mao-B) was the protein that showed the biggest effect with 
HP diet. Additionally it correlated with a shortened reaction time and inversely with 
the vitamin B12 levels in plasma. 
Mao-B belongs to the family of mitochondrial monoamine oxidases. Monoamine 
oxidases catalyse oxidative deamination of monoamines. The primary substrate of 
Mao-B is dopamine. Dopamine is a neurotransmitter that controls the flow of 
information in the central nervous system and further modulates during learning 
process. (Nieoullon 2002) It is known, that during aging (Fowler 1980) , in depression 
and Alzheimer’s disease (Adolfsson 1980; Gottfries 1985) increased Mao-B activity 
leads to increased dopamine degradation (La 1997) which results in both oxidative 
stress and decreased dopamine levels in the central nervous system. (Youdim 2006) 
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Since dopamine is an important modulator of learning processes, a decrease can 
participate in the appearance, development and progression of Alzheimer’s disease. 
In this study the correlation between the Mao-B expression and the reaction time test 
seems to confirm the hypothesis that a decreased Mao-B level improves cognitive 
abilities, in particular considering the dopamine lowering function of Mao-B. Further it 
showes that a HP diet can lead to decreaed Mao-B expression levels and therefore 
induce these better cognitive functions. 
 
8.1.2. HP related increase of Myosin regulatory light chain 2 – MLC-2 
expression in platelets 
There are five isoforms of myosin regulatory light chain 2 found in this study which 
two of them were significantly increased with HP diet.  
Myosin regulatory light chain 2 plays an important role in the regulation of smooth 
muscle and non-smooth muscle contractile activity. The phosphorylation of MLC-2 by 
MLC kinase in presence of calcium and calmodulin increases actin-activated myosin 
ATPase activity and thereby regulates the contractile activity. 
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Figure 27: Activation of myosin by phosphorylation of myosin regulatory light chain 2. 
Calmodulin binds to Ca2+ and activates myosin light chain kinase (MLCK). The calmodulin – 
MLCK complex phosphorylates myosin regulatory light chain by cleavage of ATP and 
thereby activated myosin. (Cooper 2000) 
  
The two isoformes that are significantly increased with HP diet in this study are 
supposed to be the phosphorylated ones. It has been shown by a 2D gel 
electrophoresis study that in aged skeletal muscle the phosphorylation of myosin 
regulatory light chain 2 is decreased and the pattern of their more acidic 
phosphorylated MLC-2 isoforms are quite similar to our HP related isoforms. (Gelfi 
2006) Further He et al. say that the phosphorylation of MLC-2 are physiologically 
required for the contraction of the smooth muscle. (He 2008) Continuative it may be 
assumed that a HP diet may lead to increased muscle strength.  However, hand grip 
measurements showed no increase in muscle strength after HP diet. 
 
8.1.3. Myosin regulatory light chain 2 and muscle strength 
Despite of the with HP diet increased assumed phosphorylated MLC-2 isoforms that 
might indicate increased muscle strength the muscle function test did not show any 
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improvements with HP diet. Both groups showed an increase in muscle strength but 
it is supposed to be a training effect.  
Correlating the results of the muscle strength with the MLC-2 protein intensities of the 
DIGE gels showed that the two isoforms that are supposed to be the not 
phosphorylated ones are positively associated. This result contradicts our 
expectations and literature (Gelfi 2006; He 2008) that was found.  
 
8.2. Influence of High Protein diet on plasma proteome 
After analysing the plasma proteome with 2D DIGE in the pH range 4 –7, 12 proteins 
could be identified that were changed with HP diet. Actually there were much more 
proteins found but they had to be eliminated because they probably were a bias also 
affected by the control diet.  
64 % of proteins changed by HP diet were also significanty changed during the 
control diet. This may be due to the fact that the run in phase of the study was only 
one week. This time was probably too short for the adaption to a new diet.  
Most of the significant changed proteins in both groups are part of the complement 
system. The complement system is part of the inflammatory response and has never 
been implicated in HP diet or any other diets at all.  
 
8.3. Concentration of plasma amino acids after HP diet 
There was no change in total sum of amino acids after HP diet as well as after NP 
diet. But in the single amino acids several changes could be monitored in both, the 
NP group and the HP group. This could be also due to the fact that the nutrition 
habits of the individuals differed substantially from the food in this study and the short 
run in period.  
In this study the branched chain amino acids, phenylalanin and tyrosin are increasing 
with HP diet. Harper et al. says that with a HP diet there is an adaptive increase of 
most amino acid degrading enzymes except for degrading enzymes for 
phenylalanine, tyrosine and branched chain amino acids (leucine, isoleucine and 
valine). (Harper 1984) That means that with HP diet branched chain amino acids, 
phenylalanin and tyrosin levels stay elevated while most of the other amino acids are 
declining. (Harper 1984; Harper 1989) Therefore it can be suggested that plasma 
phenylalanine, tyrosine and the branched chain amino acids are directly proportional 
to protein intake. (Harper 1989) 
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8.4. Plasma parameter analysis 
8.4.1. Cholesterols and triglycerides 
The significant decrease of LDL, HDL and total cholesterol in the NP group probably 
derives from the adaption to the new, constant way of nutrition – since there were no 
changes in alimentary composition with time in this group.  
There was a significant decrease of HDL and total cholesterol with HP diet in this 
study.  
Papakonstantinou et al. could also show in a 4 week intervention study that both a 
HP diet and a NP diet can improve LDL and total cholesterol levels in a comparable 
way. (Papakonstantinou 2010a) Further it was shown by Evangelista et al. that a HP 
diet improves LDL, HDL, total cholesterol and trigycerides levels. (Evangelista 2009) 
The cholesterol values in this study probably decreased significantly because the 
individuals had a very unhealthy way of nutrition before the study started. With this 
controlled and regulated study diet a slow improvement of the cholesterol values was 
monitored after 3 weeks.  
The decrease of HDL in the HP group was more distinct than in the NP group. 
Studying the results in more detail, the reason for this is obvious. Three of the 
individuals of the HP group had a very big decrease of their HDL values during the 
study, whereas in the NP group there was only one person with such strong 
individual changes.  
 
8.4.2. Homocysteine – Folate – Vitamin B12 
Vitamin B12 was significantly increased and homocysteine was significanty decreased 
with HP diet in this study. Folate was significantly decreased with both HP and NP 
diet. 
All three of them are take part in the methylation cycle. Methylation of DNA is a very 
important regulation mechanism of gene expression. The more a gene or a promoter 
of a gene is methylated the more tightly the DNA is packed and the harder the 
transcription of the gene is. For this methylation 5-methyl-TH4-folate is required. 
Vitamin B12 takes the methyl group of methyl-TH4-folate, attaches it to homocysteine 
and thereby TH4-folate and methionine are generated.  
  
87 
 
Figure 28: Homocysteine cycle. In presence of vitamin B12 and folate, homocysteine is 
metabolized to methionine. Thus, the concentration of homocysteine is inversely proportional 
to the concentration of vitamin B12. S-Adenosylmethionine provides the methyl group for 
DNA methylation. 
 
 
Folate, homocysteine and vitamin B12 levels are highly governed by nutrition. 
Therefore significant effects on their levels were expected with a high protein diet. 
Since the main nutritional source for vitamin B12 is meat a significant increase of this 
parameter in the HP group was expected. Already Clifton et al showed before that 
with a HP diet the vitamin B12 levels are rising. (Clifton 2008) 
Concerning the coherence between homocysteine and HP diet the literature is more 
contradictory. Jia et al showed an increase of homocysteine levels with HP diet in 
pigs for example. (Jia 2010) Haulrik et al. showed in contrast a decreased 
homocysteine level with HP diet. (Haulrik 2002) Noakes et al. could not observe any 
HP dependent changes in serum homocysteine at all. (Noakes 2005) In this study the 
extensive significant decrease of serum homocysteine with HP diet indicates a 
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positive effect of a HP diet from an animal source on the risk to sicken from 
cardiovascular diseases and osteoporosis. 
Serum folate seems to response to any change in nutrition. (Clifton 2008; Noakes 
2005) In this study both NP and HP diet caused an significant decrease in folate 
levels. 
 
8.4.3. Platelet Monoamine oxidase B expression and plasma vitamin B12 
concentration are inversely correlating 
In this study the plasma vitamin B12 levels correlate significantly, inversingly with the 
Mao-B expression levels in platelets.  
Regland et al. showed already a negative correlation between plasma vitamin B12 
levels and Mao-B activity in plateles in megaloblastic anemia and dementia patients. 
Mao-B activity was significantly reduced (to apparently normal levels) after vitamin 
B12 supplementation. (Regland 1991) Our study shows that the decreased Mao-B 
activity that results from increased vitamin B12 levels are due to the decreased Mao-B 
expression. Increased vitamin B12 levels seem not only decrease Mao-B expression 
in platelets but also in all the other cells in the body like in the brain. This could 
explain the increased cognitive function with HP diet. 
 
8.5. Future prospects 
The main findings in this study are the increased cognitive abilities that can be 
explained due to the increased viamin B12 levels due to the HP diet from an animal 
source which results in a decreased Mao-B expression which is a key player in 
dopamin degradation. This might indicate a positive effect of an animal HP diet. To 
ensure this hypothesis futher studies are needed. It would be of special interest for 
example to compare HP diets that derive from an animal and a vegan source. 
Thereby effects can be excluded that originate from the HP diet and can be 
described to the source the protein comes from. Thus it would be possible to 
distinguish the effects of an animal HP diet.  
 
 
 
 
  
89 
9.  Reference List 
 1.   (2010) DeCyder 2D Software. Version 6.5. User Manual.28-4010-06.GE 
Healthcare. 
 2.  Adolfsson R, Gottfries CG, Oreland L, Wiberg A, Winblad B (1980) Increased 
Activity of Brain and Platelet Monoamine-Oxidase in Dementia of Alzheimer 
Type. Life Sciences 27:1029-1034 
 3.  Alberts, Johnson, Walter, Lewis, Raff, Roberts, Walter (2002a) Chaper 16 The 
Cytoskeleton. In: Garland Sciences (ed) Molecular Biology of the Cell. New 
York, 
 4.  Alberts, Johnson, Walter, Lewis, Raff, Roberts, Walter (2002b) Molecular 
Biology of the Cell. In: Garland Sciences (ed) New York, p 1296 
 5.  Beck T (2002) Vielfältige Aufgaben der Blutzellen. Pharmazeutische Zeitung 
 6.  Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995) A quantitative 
assessment of plasma homocysteine as a risk factor for vascular disease. 
Probable benefits of increasing folic acid intakes. JAMA 274:1049-1057 
 7.  Campbell WW, Trappe TA, Jozsi AC, Kruskall LJ, Wolfe RR, Evans WJ (2002) 
Dietary protein adequacy and lower body versus whole body resistive training in 
older humans. J Physiol 542:631-642 
 8.  Castaneda C, Charnley JM, Evans WJ, Crim MC (1995) Elderly women 
accommodate to a low-protein diet with losses of body cell mass, muscle 
function, and immune response. Am J Clin Nutr 62:30-39 
 9.  Cavallini DC, Abdalla DS, Vendramini RC, Bedani R, Bomdespacho LQ, Pauly-
Silveira ND, de Valdez GF, Rossi EA (2009) Effects of isoflavone-
supplemented soy yogurt on lipid parameters and atherosclerosis development 
in hypercholesterolemic rabbits: a randomized double-blind study. Lipids Health 
Dis 8:40 
 10.  Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G (2004) Purine-rich 
foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 
350:1093-1103 
 11.  Clifton PM, Keogh JB, Noakes M (2008) Long-term effects of a high-protein 
weight-loss diet. Am J Clin Nutr 87:23-29 
 12.  Cooper (2000) The Cell - A Molecular Approach. In: Sinauer Associates (ed) 
Sunderland, 
  
90 
 13.  Elmadfa, Leitzmann (1998) Ernährung des Menschen. In: Ulmer UTB (ed) 
Stuttgard, pp 163-187 
 14.  Evangelista LS, Heber D, Li Z, Bowerman S, Hamilton MA, Fonarow GC (2009) 
Reduced body weight and adiposity with a high-protein diet improves functional 
status, lipid profiles, glycemic control, and quality of life in patients with heart 
failure: a feasibility study. J Cardiovasc Nurs 24:207-215 
 15.  Fam AG (2002) Gout, diet, and the insulin resistance syndrome. J Rheumatol 
29:1350-1355 
 16.  Fischer TH, Barton DW, Krause KH, White TE, Campbell KP, White GC (1989) 
The identification of sarcoplasmic reticulum terminal cisternae proteins in 
platelets. Biochem J 263:605-608 
 17.  Fowler CJ, Wiberg A, Oreland L, Marcusson J, Winblad B (1980) The effect of 
age on the activity and molecular properties of human brain monoamine 
oxidase. J Neural Transm 49:1-20 
 18.  Gawaz (2001) Blood Platelets. In: Thieme Verlag (ed) Stuttgart, pp 1-25 
 19.  Gelfi C, Vigano A, Ripamonti M, Pontoglio A, Begum S, Pellegrino MA, Grassi 
B, Bottinelli R, Wait R, Cerretelli P (2006) The human muscle proteome in 
aging. J Proteome Res 5:1344-1353 
 20.  Gnatenko DV, Dunn JJ, McCorkle SR, Weissmann D, Perrotta PL, Bahou WF 
(2003) Transcript profiling of human platelets using microarray and serial 
analysis of gene expression. Blood 101:2285-2293 
 21.  Gottfries CG (1985) Alzheimer's disease and senile dementia: biochemical 
characteristics and aspects of treatment. Psychopharmacology (Berl) 86:245-
252 
 22.  Grüner Bericht (2004) Grüner Bericht 2004. In: Bundesministerium für Land- 
und Forstwirtschaft UuW (ed) Wien, 
 23.  Harper AE, Miller RH, Block KP (1984) Branched-chain amino acid metabolism. 
Annu Rev Nutr 4:409-454 
 24.  Harper AE, Peters JC (1989) Protein intake, brain amino acid and serotonin 
concentrations and protein self-selection. J Nutr 119:677-689 
 25.  Haulrik N, Toubro S, Dyerberg J, Stender S, Skov AR, Astrup A (2002) Effect of 
protein and methionine intakes on plasma homocysteine concentrations: a 6-
mo randomized controlled trial in overweight subjects. Am J Clin Nutr 76:1202-
1206 
  
91 
 26.  He WQ, Peng YJ, Zhang WC, Lv N, Tang J, Chen C, Zhang CH, Gao S, Chen 
HQ, Zhi G, Feil R, Kamm KE, Stull JT, Gao X, Zhu MS (2008) Myosin light 
chain kinase is central to smooth muscle contraction and required for 
gastrointestinal motility in mice. Gastroenterology 135:610-620 
 27.  Jakobsen LH, Kondrup J, Zellner M, Tetens I, Roth E (2010) Effect of a high 
protein meat diet on physiological functions: a randomised controlled dietary 
intervention trial in healthy men . Clin Nutr 
 28.  Jia Y, Hwang SY, House JD, Ogborn MR, Weiler HA, O K, Aukema HM (2010) 
Long-term high intake of whole proteins results in renal damage in pigs. J Nutr 
140:1646-1652 
 29.  Karpatkin S, Charmatz A, Langer RM (1970) Glycogenesis and 
glyconeogenesis in human platelets. Incorporation of glucose, pyruvate, and 
citrate into platelet glycogen; glycogen synthetase and fructose-1,6-
diphosphatase activity. J Clin Invest 49:140-149 
 30.  Krivosikova Z, Krajcovicova-Kudlackova M, Spustova V, Stefikova K, 
Valachovicova M, Blazicek P, Nemcova T (2010) The association between high 
plasma homocysteine levels and lower bone mineral density in Slovak women: 
the impact of vegetarian diet. Eur J Nutr 49:147-153 
 31.  La RA, Koehler KM, Wayne SJ, Chiulli SJ, Haaland KY, Garry PJ (1997) 
Nutritional status and cognitive functioning in a normally aging sample: a 6-y 
reassessment. Am J Clin Nutr 65:20-29 
 32.  Lodish, Berk, Zipursky, Matsudaira, Darnell (2000) Molecular Cell Biology. In: 
W.H.Freeman (ed) New York, 
 33.  Löffler, Petrides (2002a) Biochemie und Pathobiochemie. In: Springer-Verlag 
GmbH (ed) Heidelberg; Berlin, pp 34-49 
 34.  Löffler, Petrides (2002b) Biochemie und Pathobiochemie. In: Springer-Verlag 
GmbH (ed) Heidelberg; Berlin, pp 541-543 
 35.  Löffler, Petrides (2002c) Biochemie und Pathobiochemie. In: Springer-Verlag 
GmbH (ed) Heidelberg; Berlin, pp 1041-1073 
 36.  Michlmayr A. (2007) Changes in the plasma proteome of mamma carcinoma 
patients after chemotherapy. 
 37.  Mikkelsen PB, Toubro S, Astrup A (2000) Effect of fat-reduced diets on 24-h 
energy expenditure: comparisons between animal protein, vegetable protein, 
and carbohydrate. Am J Clin Nutr 72:1135-1141 
  
92 
 38.  Nieoullon A (2002) Dopamine and the regulation of cognition and attention. 
Prog Neurobiol 67:53-83 
 39.  Noakes M, Keogh JB, Foster PR, Clifton PM (2005) Effect of an energy-
restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, 
low-fat diet on weight loss, body composition, nutritional status, and markers of 
cardiovascular health in obese women. Am J Clin Nutr 81:1298-1306 
 40.  Nothlings U, Wilkens LR, Murphy SP, Hankin JH, Henderson BE, Kolonel LN 
(2005) Meat and fat intake as risk factors for pancreatic cancer: the multiethnic 
cohort study. J Natl Cancer Inst 97:1458-1465 
 41.  Omenn GS, Beresford SA, Motulsky AG (1998) Preventing coronary heart 
disease: B vitamins and homocysteine. Circulation 97:421-424 
 42.  Paddon-Jones D, Sheffield-Moore M, Zhang XJ, Volpi E, Wolf SE, Aarsland A, 
Ferrando AA, Wolfe RR (2004) Amino acid ingestion improves muscle protein 
synthesis in the young and elderly. Am J Physiol Endocrinol Metab 286:E321-
E328 
 43.  Papakonstantinou E, Triantafillidou D, Panagiotakos DB, Koutsovasilis A, 
Saliaris M, Manolis A, Melidonis A, Zampelas A (2010b) A high-protein low-fat 
diet is more effective in improving blood pressure and triglycerides in calorie-
restricted obese individuals with newly diagnosed type 2 diabetes. Eur J Clin 
Nutr 64:595-602 
 44.  Papakonstantinou E, Triantafillidou D, Panagiotakos DB, Koutsovasilis A, 
Saliaris M, Manolis A, Melidonis A, Zampelas A (2010a) A high-protein low-fat 
diet is more effective in improving blood pressure and triglycerides in calorie-
restricted obese individuals with newly diagnosed type 2 diabetes. Eur J Clin 
Nutr 64:595-602 
 45.  Regland B, Gottfries CG, Oreland L (1991) Vitamin B12-induced reduction of 
platelet monoamine oxidase activity in patients with dementia and pernicious 
anaemia. Eur Arch Psychiatry Clin Neurosci 240:288-291 
 46.  Rodriguez NR, Garlick PJ (2008) Introduction to Protein Summit 2007: 
exploring the impact of high-quality protein on optimal health. Am J Clin Nutr 
87:1551S-1553S 
 47.  Short KR, Vittone JL, Bigelow ML, Proctor DN, Nair KS (2004) Age and aerobic 
exercise training effects on whole body and muscle protein metabolism. Am J 
Physiol Endocrinol Metab 286:E92-101 
  
93 
 48.  Silbernagl, Despopoulos (2007) Taschenatlas Physiologie. In: Thieme Verlag 
(ed) Stuttgart, p 102 
 49.  Speckmann, Hescheler, K, ö, h, l, i, n (2008) Physiologie. In: Elsevier (ed) 
München, pp 174-202 
 50.  Taylor EF, Burley VJ, Greenwood DC, Cade JE (2007) Meat consumption and 
risk of breast cancer in the UK Women's Cohort Study. Br J Cancer 96:1139-
1146 
 51.  Vary TC, Jefferson LS, Kimball SR (1999) Amino acid-induced stimulation of 
translation initiation in rat skeletal muscle. Am J Physiol 277:E1077-E1086 
 52.  Volpi E, Ferrando AA, Yeckel CW, Tipton KD, Wolfe RR (1998) Exogenous 
amino acids stimulate net muscle protein synthesis in the elderly. J Clin Invest 
101:2000-2007 
 53.  Weyrich AS, Zimmerman GA (2004) Platelets: signaling cells in the immune 
continuum. Trends Immunol 25:489-495 
 54.  Williams PT (2008) Effects of diet, physical activity and performance, and body 
weight on incident gout in ostensibly healthy, vigorously active men. Am J Clin 
Nutr 87:1480-1487 
 55.  Wong WK, Chen K, Shih JC (2003) Decreased methylation and transcription 
repressor Sp3 up-regulated human monoamine oxidase (MAO) B expression 
during Caco-2 differentiation. J Biol Chem 278:36227-36235 
 56.  Yakub M, Iqbal MP, Iqbal R (2010) Dietary patterns are associated with 
hyperhomocysteinemia in an urban Pakistani population. J Nutr 140:1261-1266 
 57.  Youdim MB, Bakhle YS (2006) Monoamine oxidase: isoforms and inhibitors in 
Parkinson's disease and depressive illness. Br J Pharmacol 147 Suppl 1:S287-
S296 
 58.  Zellner M, Oehler R, Umlauf E, Ramberger M, Pirchegger P, Babeluk R, 
Lamont J, Veitinger M (2009) Platelet proteins with low biologial variation for the 
use as normalisaton tool. 
 59.  Zellner M, Winkler W, Hayden H, Diestinger M, Eliasen M, Gesslbauer B, Miller 
I, Chang M, Kungl A, Roth E, Oehler R (2005) Quantitative validation of 
different protein precipitation methods in proteome analysis of blood platelets. 
Electrophoresis 26:2481-2489 
 60.  Zimmerman P, Fimm B (2007) Test for Attentional Performance (TAP). 
 
  
94 
10. Appendix 
10.1. Curriculum vitae – Rita Babeluk 
 
 
 
Geboren am:  31. 08. 1986 
Staatsangehörigkeit: Österreich 
Familienstand:  ledig 
 
 
 
 
 
Ausbildung 
 
seit 2004  Diplomstudium der Molekularen Biologie an der Universität Wien 
 
18. 06. 2004  Maturaabschluss mit ausgezeichnetem Erfolg 
 
1996-2004 Bundesgymnasium GRG23 Alterlaa 
 
1992-1996 Öffentliche Volksschule Putzendoplergasse, 1230 Wien 
 
 
 
 
Wissenschaftliche Arbeiten 
 
1. 12. 2008 – 31. 10. 2010 wissenschaftliche Mitarbeit (auf 20 h Basis) im 
Institut für Physiologie an der Medizinischen 
Universität Wien bei Dr. Maria Zellner 
 
1. 02. 2008 – 30. 11. 2008 wissenschaftliche Mitarbeit (auf 40 h Basis) im 
chirurgischen Forschungslabor des AKH Wien bei 
Dr. Maria Zellner 
 
1. 02. 2005 – 31. 01. 2008  wissenschaftliche Mitarbeit (2 Tage pro Woche) im 
chirurgischen Forschungslabor des AKH Wien bei 
Dr. Maria Zellner 
 
 
 
 
 
 
 
 
 
  
95 
Publikationen 
 
• Specific binding of hypochlorite-oxidized HDL to platelet CD36 triggers 
proinflammatory and procoagulant effects. 
 
Assinger A, Koller F, Schmid W, Zellner M, Babeluk R, Koller E, Volf I. 
Atherosclerosis. 2010 Sep;212(1):153-60. Epub 2010 May 13. 
 
• Biological variation of the platelet proteome in the elderly population and 
its implication for biomarker research  
 
Winkler W, Zellner M, Diestinger M, Babeluk R, Marchetti M, Goll A, 
Zehetmayer S, Bauer P, Rappold E, Miller I, Roth E, Allmaier G, Oehler R  
Mol Cell Proteomics 2008; 7: 193-203 
 
• Fluorescence-based western blotting for quantitation of protein 
biomarkers in clinical samples 
 
Zellner M, Babeluk R, Diestinger M, Pirchegger P, Skeledzic S, Oehler R. 
Electrophoresis. 2008 Aug; 29(17): 3621-7. 
 
Submitted 
 
• A proteomics study reveals a predominant change in MaoB expression 
in platelets of healthy volunteers after high protein diet - Relationship to 
the methylation cycle 
 
Zellner M, Babeluk R, Jakobsen LH, Gerner, Erich C, Roth E, Kondrup J. 
Journal of Neuronal Transmission 
 
 
 
Abstracts 
 
• Impact of high protein diet on platelet proteome in humans 
 
R. Babeluk, L.H. Jakobsen, J. Kondrup, Christopher Gerner, E. Roth, S. 
Baumann and M. Zellner 
 
• Implication of glutathione S-transferase omega 1 in Alzheimer’s disease 
and its dependence on the presence of Apo E4 
 
R. Babeluk, S. Kappel, E. Umlauf, M. Zellner 
 
• Different chemotherapeutic regime induces specific changes in the 
plasma proteome 
 
S. Baumann, A. Michlmayr, R.Babeluk, T. Bachleitner, M.Gnant, U.Bartsch,  
T.Grünberger, M. Bergmann and R. Oehler 
 
  
96 
• Comparative platelet proteome profinling of Alzheimer’s and Parkinson’s 
disease patients 
 
M. Zellner, E. Umlauf, M. Diestinger, P. Pirchegger, E. Rappold, N. Kotzailias, 
C. Gerner, R. Babeluk, F. Garo, R. Oehler and J. Lamont 
 
• Comparative platelet proteome profiling from dementia and parkinson´s 
disease patients 
 
M. Zellner, M. Diestinder, P. Pirchegger, E. Umlauf, E. Rappold, N. Kotzailias, 
C. Gerner, W. Winkler, R. Babeluk, F. Garo, R. Oehler  
 
• Platelet proteins with low biological variation for the use as normalisation 
tool 
 
M. Zellner, R. Oehler, E. Umlauf, M. Ramberger, P. Pirchegger, R. Babeluk, J. 
Lamont, M. Veitinger 
 
 
Berufsbezogene Fortbildungen und Posterpräsentationen 
 
Sept 2006 AUPA Proteomics Symposium 
Sept 2007 Kongress für Zivililsationserkrankungen und Alters-Assoziierte 
Erkrankungen – Prädiktion, Prävention und Therapiemonitoring  
Sept 2007 AUPA Proteomics Symposium mit Kurs 
Sept 2008 30th ESPEN Congress 
Okt 2008 Phosphoproteomics Seminar with Practical Workshop 
Juni 2009 5. PhD – Symposium 09  
Aug 2009 31th ESPEN Congress 
Okt 2009 3rd Central and Eastern European Proteomics Conference 
 
 
Preise 
 
• Posterpreis: 
 
Implication of glutathione S-transferase omega 1 in Alzheimer’s disease and its 
dependence on the presence of Apo E4 
R. Babeluk, S. Kappel, E. Umlauf, M. Zellner 
AACC Annual Meeting; Chicago, Juli 2009 
 
• Student Travel Grant: 
 
Impact of high protein diet on platelet proteome in humans 
R. Babeluk, L.H. Jakobsen, J. Kondrup, Christopher Gerner, E. Roth, S. Baumann 
and M. Zellner 
3rd Central and Easter European Proteomics Conference; Budapest, Oktober 2009 
 
 
 
 
  
97 
weitere Jobs 
 
9. 06. 2006 – 1. 02. 2008 Mitarbeiterin bei Patentanwalt Dipl.-Ing. Mag. Michael 
Babeluk 
 
2005 – 2006  Servicekraft im Bereich Catering bei Großveranstaltungen 
 
2001 – 2005 Nachhilfe für Unter- und Oberstufe Englisch und 
Mathematik 
 
 
Sprachen 
 
Deutsch – Muttersprache  
Englisch – fließend in Wort und Schrift 
Spanisch – Maturaniveau 
 
 
Persönliche Interessen 
 
Musik (Klavier, Cello), Lesen, Reisen 
 
 
  
98 
10.2. Abbrevations 
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Clinical Nutrition. Chaper 5.1.2, 5.1.5, 5.1.6, 5.4.2, 5.4.3, 6.1.1, 6.4.2 and 6.4.3 are 
part of the manuscript: “A proteomics study reveals a predominant change in MaoB 
expression in platelets of healthy volunteers after high protein diet - Relationship to 
the methylation cycle” that are in Journal of Neural Transmission. 
 
